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Introduction 
Of the various forms of diabetes mellitus, two types predominate. One of these 
types is characterized by a later onset and in general has a favorable prognosis 
when treated with insulin or orally administered anti-diabetic drugs. The other, 
the juvenile type, usually develops at younger ages and has, according to 
WHITE (148), a life expectation which on average is 17 years shorter than nor-
mal, even under insulin treatment. In addition, juvenile diabetes mellitus often 
results in severe disability due to vascular, nephrogenic, ophthalmogenic, and 
neurogenic complications. 
The exact number of diabetes mellitus patients is not known. The Diabetes 
Fact Book 1962 (34) gave a figure of 2.9 million for the United States, but 
LILLEHEI eta/. (95) put the number at 4 to 5 million, 4 to 5 per cent being of 
the juvenile type. WHITE (148) reported that there were 118,000 juvenile dia-
betics in the U.S.A. in 1956. 
According to the Netherlands Diabetics Association, there are 125,000 known 
cases of diabetes mellitus in The Netherlands and an equal number of unknown 
cases may be assumed, which would bring the total to 250,000 cases. The 
Association estimates that 1,000 of these patients suffer from the juvenile form, 
but if the American estimate of 4 per cent is applied the number of juvenile 
diabetics in The Netherlands would be about 10,000. 
According to these American sources, diabetes mellitus is among the diseases 
with the most rapidly increasing incidence. No data are available on this point 
for The Netherlands, because little epidemiological research has been done in 
this field (llO). 
Most endocrinologists (88) are in agreement that the primary cause of dia-
betes mellitus is a disturbance localized in the endocrine part of the pancreas. 
Among other considerations, this raised the question of whether pancreas 
transplantation might be a suitable form of treatment for the group of patients 
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with the juvenile type of diabetes mellitus in whom insulin therapy is ultimately 
inadequate. The pancreas is, however, a complex organ, both anatomically and 
physiologically, and this explains the number of surgical techniques which have 
been developed and applied for pancreas transplantation. All of these methods 
represent complicated surgical procedures; the number of successful transplan-
tations in man has been very low and the mortality and morbidity among the 
recipients quite high (63). 
The value of pancreas transplantation would be increased by simplification 
of the surgery involved, comparable to kidney transplantation. This attracted 
the interest of experimental surgery. In addition, an experimental model could 
solve some of the remaining problems related to the pathophysiology of dia-
betes mellitus. Such problems can, for example, be approached by transplan-
tation of a pancreas in dogs with the juvenile form of diabetes mellitus. 
These considerations led us to investigate the possibilities for the develop-
ment of a simple form of pancreas transplantation. 
CHAPTER I 
Problems associated with pancreas 
transplantation 
1. HISTORICAL REVIEW 
JOHANN CONRAD VON BRUNNER (1652-1727)( 19) was the first to perform resec-
tion of the pancreas in the dog. During one of his experiments he noticed that 
a dog became extremely thirsty after the operation. This was very probably 
the first case of experimentally induced diabetes mellitus, but it was not until 
1890 that the relationship between the pancreas and diabetes mellitus was 
discovered by MERINO & MINKOWSKI (104). 
SSOBOLEW (1901) (131) was the first to describe the ligation of the pancreatic 
duct in vivo, which he performed in dogs, cats, and rabbits. He followed the 
post-operative course in these animals for 60, 100, and 400 days, respectively, 
and found no glucose in the urine over these periods. Microscopically, he found 
atrophy of the acinar cells, whereas the islets of Langerhans remained intact. 
This led him to conclude that the islets of Langerhans were the most important 
factor in diabetes mellitus. 
In 1922, BANTING et a/. (7) succeeded in producing an extract of pancreas 
tissue, which they used to treat animals suffering from diabetes mellitus. Ten 
weeks after ligation of the pancreatic duct, when acinar atrophy had developed, 
the favorable effect of the extract could still be demonstrated. 
Meanwhile, HEDON (65) had performed the first pancreas autotransplantation 
in 1892 by subcutaneous implantation of a pancreatic segment with the blood 
vessels intact. After new vessels had grown into the glandular tissue, he cut the 
original vessels and found that the transplant remained viable. 
In the following period pancreas autotransplantations were mainly per-
formed by physiologists (33, 64, 78) to investigate hormonal and enzymatic 
mechanisms in the organ. These studies showed that the hydrochloric acid in 
14 TRANSPLANTATION OF DUCT-LIGATED PANCREAS 
the duodenum stimulated the exocrine functioning of a pancreas implanted in 
the neck (64) and that such implants caused a temporary lowering of the glucose 
level in the urine. The anastomoses established by these authors were primitive, 
using Payr's cannulas as described by BoniN & DELREZ (16), who investigated 
the early development of thromboses in the anastomoses made for pancreas 
transplants in the neck. Attempts were also made (18, 73, 128) to retain the 
function of subcutaneously implanted pancreas tissue without vascular anasto-
moses, but unsuccessfully. 
Among the authors who ligated the pancreatic duct were SWAN & RUNDLES 
(134), who clearly indicated in 1957 that they saw their work as a continuation 
of the investigations done by HEDON (65). In 1957, too, LICHTENSTEIN & BAR-
SCHAK (92) performed a pancreas allotransplantation in a dog specifically to 
study the therapeutic possibilities of pancreas transplantation for future use in 
man. Unsuccessful allotransplantations with ligated ducts in animals were 
described by BRooKs & GIFFORD (17), but they were the first to perform pan-
creas implantation in man. They transplanted pancreas tissue from a fetus to 
the mother, implanting it in them. quadriceps femoris. Of their 6 patients, only 
one showed a reduced insulin requirement, but even this was not significant. 
In 1962, DEJODE & HowARD (31) were the first to report a series of successful 
pancreas allotransplantations in dogs. They used the celiac artery as afferent 
vessel and ligated all of the vessels that did not run to the pancreas. The gastro-
duodenal vein was used as the efferent vessel, and the portion of the duodenum 
into which the exocrine ducts emptied was included in the graft. The transplants 
functioned well but were rejected on average after 6 days. Immunosuppressive 
drugs were not used. Of the investigators who transplanted pancreas tissue 
without the use of vascular anastomoses, DuBOIS & GONET (37) and HoUSE 
eta/. (68) found a transient effect in the form of a drop in the glucose level in 
the blood of rats and hamsters, respectively. 
The first pancreas allotransplantation in man was performed in December of 
1966 by LILLEHEI's group and was described by KELLY eta/. (81). 
2. SPECIFIC PROBLEMS 
As organ, the pancreas has an exocrine and an endocrine function. The digestive 
enzymes are formed in the acinar cells and transported via the pancreatic ducts 
to the duodenum. The hormones formed in the islets of Langerhans are carried 
via the portal vein to the liver before they reach the large circulation. 
The pancreas has 3 afferent blood vessels: the superior pancreaticoduodenal 
artery, the inferior pancreaticoduodenal artery, and the splenic artery. The 
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venous drainage is analogous except that all of the veins converge in the portal 
vein. The pancreas is also attached to the duodenum and in close contact with 
the choledochus duct. For further details reference is made to the textbooks on 
anatomy (58, 108), physiology (122, 138), and histology (9,88). The described 
anatomy means that in man an orthotopic allotransplantation involves a major 
and technically very complicated operation. 
As the introduction indicates, the main concern in pancreas transplantation 
is the endocrine function of the organ. Theoretically, therefore, the best site 
for a pancreas transplant would not be the original anatomical position and 
preference would be given to transplantation to another site with only the 
endocrine function preserved. This raises a number of problems on which 
extensive research has been done but concensus has not been reached. These 
problems will be discussed successively. 
2.1. The influence of ligation of the exocrine ducts on the pancreas 
As already mentioned, SSOBOLEW (131) ligated the exocrine ducts of the pan-
creas in dogs, cats, and rabbits and found atrophy and fibrosis of the acini but 
no changes in the islets of Langerhans. BANTING et a!. (7) performed similar 
experiments and found insulin in the islet tissue 10 weeks after ligation of the duct. 
In 1943, DRAGSTEDT (35) was the first to mention deterioration of the endo-
crine function of the pancreas after ligation of the ducts, leading in some cases 
to diabetes mellitus. HIEBERT et a!. (66) ligated the duct but, like ANLYAN 
eta!. (4), were unable to demonstrate an influence on the endocrine function. 
AMBROMOVAGE et a!. (2) followed-up 10 dogs for 83 weeks after ligation of 
the pancreatic duct. During this period they administered glucose orally, which 
led to an abnormal insulin reaction and a glucose tolerance test (OTT) with a 
a diabetic curve. IDEZUKI et al. (74) separated the head and tail of the canine 
pancreas, ligated the pancreatic duct of the tail, and subsequently removed the 
head. Two-thirds of the surviving dogs showed similarly diabetic OTT curves. 
No such curves were obtained for dogs in which these steps were done in one 
operation. 
CHAYA et al. (22), who ligated the pancreatic ducts in dogs used as donors 
several weeks later when transplantation was performed, found no difference 
in the oral OTT results obtained before and after the ligation. REEMTSMA et 
a!. (!21) performed similar experiments in dogs and rats and directly after the 
operation found no difference between the serum glucose levels in transplants 
with and without ligation of the pancreatic duct. In isologous rat strains the 
blood-sugar values found 150 days after transplantation of a pancreas with a 
ligated duct were not diabetic, but when the transplant was extirpated these 
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values immediately rose. Using a similar technique in dogs, SEDDON & HOWARD 
(127) saw normal serum glucose levels after transplantation. One of their dogs 
could be followed for 75 days post-operatively. 
2.2. Pancreatitis 
All of the authors who ligated the pancreatic duct report that pancreatitis 
developed, in most cases a mild edematous form. The necrotising form was 
only seen in a few cases. 
LARGIADER et a/. (82, 83) did not observe pancreatitis after orthotopic trans-
plantation of the pancreas with duodenum, i.e., without ligation of the duct 
and with end-to-side suturing of the donor's portal vein to the recipient's portal 
vein. Others authors (63, !53), however, found elevated amylase levels and 
sometimes even necrotising pancreatitis in pancreas transplants in which the 
pancreatic duct had not been ligated. 
Lastly, TEIXEIRA & BERGAN (136) demonstrated that the venous anastomosis 
should be made as ample as possible to avoid pancreatitis. Necrotising pan-
creatitis was seen significantly more frequently for end-to-end anastomoses 
(portal vein on iliac vein). 
2.3. Insulin and the liver 
Insulin is secreted by the beta cells directly into the blood of the portal vein 
and p:1sses through the liver before reaching the large circulation. KAPLAN & 
MADISON (80) showed that half of the insulin is withdrawn from the blood in 
the liver, and BEGER eta/. (10) even measured an 82 per cent drop in the portal 
insulin level after intra-abdominal operations. ZIMMERMANN (153) found higher 
insulin levels in the portal blood than in the blood in the vena cava. When, 
however, an anastomosis is established between the portal and caval veins, 
passage through the liver is excluded and higher insulin concentrations would 
be expected in the peripheral venous blood. Nevertheless, WADDELL & Suss-
MAN (143) did not see a significant elevation of the insulin level in the peripheral 
blood after making a porto-caval shunt, and no difference in effect on the 
blood-sugar level was found by STARZL eta/. (133), who administered insulin 
peripherally and via the portal circulation. LEVEEN eta/. (91), to the contrary, 
saw an improvement in experimental canine diabetes when the venous drainage 
of the pancreas by-passed the liver, and HEARN & PATON (61) saw an improve-
ment of the diabetic state in diabetic patients given a porto-caval shunt. 
In heterotopic pancreas transplantations, too, the insulin will not reach the 
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liver directly, and anomalous insulin patterns would be expected. BERGAN & 
TEIXEIRA (12) indeed found higher insulin levels in the peripheral blood of dogs 
after heterotopic than after orthotopic transplantations. This finding could not, 
however, be confirmed by LARGIADER (85), !DEZUKI et a/. (75), or LILLEHEI 
eta/. (95). SELLS eta/. (129) found higher insulin levels after heterotopic trans-
plantations in the pig, but ZIMMERMANN eta/. (!52) could not reproduce their 
results. 
2.4. Denervation 
Like every transplanted organ, the transplanted pancreas will be completely 
denervated. The effect of vagotomy on the enzymatic and hormonal function 
of the pancreas is of interest. HoussAY eta/. (71) found no influence of vago-
tomy on the OTT in the dog, but LIEDBERG et a/. (93) showed in rats that the 
insulin index (6 insulin/6 glucose) is significantly lower after vagotomy. 
RussEL et a/. (125) investigated the effect of vagotomy on glucagon produc-
tion and found a distinctly reduced secretion of the hormone after vagotomy in 
man. SMITH et a/. (130) did a study in man by investigating the influence of 
truncal vagotomy and selective vagotomy on the excretion of pancreatic en-
zymes, and GovAERTS & KIEKENS (46) performed truncal vagotomy in dogs. 
In both studies enzyme production was lower after the operation. 
2.5. Ischemia 
JOISON (79) avoided an ischemic period during pancreas transplantations in 
dogs by leading blood from the recipient through the donor's pancreas via the 
femoral vessels. The animals died immediately after the transplantation; apart 
from a sudden sharp drop of the calcium level, no reason for the fatal course 
could be found. 
BINDER eta/. (14) demonstrated that in situ the endocrine part of the canine 
pancreas can survive an hour of ischemia without perfusion and under normo-
thermic conditions. The serum amylase level was elevated after ischemia in all 
of their experiments. 
CERRA et al. (21) drew attention to the fact that in pancreas transplantations 
with ligated ducts and prolonged ischemia, the recipient shows abnormally 
high serum insulin levels and low glucose values in the period immediately 
after the operation. According to these authors, the explanation of these find-
ings is that ischemia leads to damage of the beta cells, which releases the active 
insulin localized in the granules of such cells. 
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2.6. Rejection 
Allotransplantation of the pancreas leads to rejection of the organ, because 
foreign proteins activate cellular and humoral defence mechanisms. The first 
investigators to perform successful experimental pancreas allotransplanta-
tions (31, 48, 82, 113, 120) reported an organ survival time of 6 to II days. Later, 
REEMTSMA et a/. (121) used mercaptopurine and azathioprine as immunosup-
pressive drugs and obtained longer organ survival in transplants, both with 
and without ligation of the pancreatic duct. Many authors (51, 62, 76, 94, !52) 
applied a combination of azathioprine and prednisone. We investigated the 
influence of tissue typing and anti-lymphocyte serum (ALS) (55). 
The parameters reflecting rejection are still uncertain. A number of authors 
(13,49, 77,86, !53) observed elevation of the serum amylase level just before 
rejection, and GRENIER et a/. (51) reported the occurrence of hyperinsulism 
during rejection without a change in the serum glucose level. RoMIEU eta/. (123) 
pointed out that the blood-sugar level does not rise until the rejection process 
is almost completed, and the same conclusion was reached by ZiMMERMANN (!53) 
and OTA eta/. (113), who are of the opinion that a sudden elevation of the serum 
glucose level after pancreas allotransplantation is more indicative of acute 
thrombosis than of rejection. VAN HEE (63) considered the occurrence of lipa-
semia to be the most constant initial sign of rejection. 
3. TECHNICAL POSSIBILITIES 
Several surgical transplantation techniques have been developed for pancreatic 
grafts with vascular anastomoses. 
The pancreas can be implanted at the original anatomical position (ortho-
topic) or at another site (heterotopic transplantation), with or without ligation 
of the pancreatic ducts. 
Orthotopic pancreas allotransplantation was described by LARGIADER et a/. 
(82,83,84) and later by others (72, 152). With this method the duodenum is 
included, and a duodenal-intestinal anastomosis is made. 
ZIMMERMANN (!53) performed porcine orthotopic transplantations without 
inclusion of the duodenum, but maintained enzyme secretion by a Roux en Y 
anastomosis of the jejunum on the pancreas. 
To the best of our knowledge, orthotopic transplantation with ligation of the 
pancreatic duct have not been performed. 
For heterotopic pancreas al/otransplantations the vascular relations permit 
three localizations: in the neck, with vascular anatomoses to the carotid artery 
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and the jugular vein; in the abdomen on the aorta and caval vein below the 
renal blood vessels, and in the left or right fossa iliaca, the anastomoses being 
made with the iliac vessels. 
Some authors (36, 48) implanted the pancreas in the neck region with pre-
servation of the enzyme secretion. Others ligated the pancreatic ducts and 
implanted the pancreas in the abdomen or a fossa iliaca. The latter method 
was preferred by LUCAS eta/. (98), REEMTSMA eta/. (121), and COUINAUD & 
MALTA-BEY (30), but they transplanted only part of the organ (the tail). 
BERGAN et a/. (11) transplanted the entire organ with ligated ducts, using the 
celiac artery of the transplant as arterial afferent and as venous efferent the 
portal vein, which were sutured to the recipient's aorta and caval vein under 
the renal vessels. 
However, most of the experimental pancreas transplantations and all of those 
in man have been heterotopic, almost always with intact drainage of the 
pancreatic enzymes. Such heterotopic transplantations of the pancreas with the 
duodenum have been performed by many investigators (36,63,67, 77,96, 153). 
In these pancreas-duodenum (PD) grafts the duodenum was connected to the 
digestive tract or led out via the skin as a fistula on one side, the other end being 
closed as described by MURAT eta/. (111). 
MEYER eta/. (107) did not include the duodenum but insured the transport 
of the enzymes with a Roux en Y loop on the cut pancreas. This method was 
also used by AQUINA eta/. (5). GuEDMAN eta/. (42) used a pancreatic duct-
ureter anastomosis in both dogs and man to obtain outflow of pancreatic 
enzymes via the bladder. 
4. CLINICAL PANCREAS TRANSPLANTATIONS 
Up to December 1974, 36 human pancreas transplantations had been reported. 
In 12 of these cases, some of them very recent, the organs functioned for only 
a few days or not at all, and therefore no other details are available. The other 
cases will be briefly discussed here. 
4.1. Body and tail transplantations 
In these cases the pancreas was transplanted without the head and with ligation 
of the pancreatic ducts. Five transplantations of this type have been performed. 
In a case reported by GLIEDMAN eta/. (42) a large amount of amylase-rich 
fluid accumulated around the transplant. The pancreas functioned well, but 
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not the kidney transplanted at the same time. Five weeks after the operation, 
when sepsis developed and the patient died, the pancreas was still capable of 
correcting elevated blood sugar levels without the administration of insulin. 
In the other 4 cases, which included the first human pancreas transplantation, 
performed by LILLEHEI and described by KELLY eta/. (81) in !966, the organ 
functioned for only 5 to 6 days. 
4.2. Pancreatico-duodenal transplantations 
Sixteen operations of this type have been performed. The longest duration of 
organ function was 12§ months; at death, due to sepsis, the pancreas transplant 
was functioning well but the simultaneously transplanted kidney had had to be 
removed because of rejection (94). CONOLLY et a/. (28) lost their patient with 
the longest survival time, who was in good condition 10 months after the 
operation, in an automobile accident. 
The function of the other pancreatico-duodenal transplants varied in dura-
tion from nil to about 8 months. Of interest in this connection is the report by 
LtLLEHEI et a/. (96) of the death of a patient due to perforation of the simul-
taneously transplanted duodenum as the result of rejection duodenitis. 
Of the 16 PD-graft patients, 12 have died. Four are still alive, but without 
the transplant; in these cases the organ was removed and the patient put back 
on insulin therapy. CONOLLY eta/. (28) recommend excision of the transplant 
at the least sign to rejection. 
4.3. Transplantations with pancreatic duct to ureter anastomosis 
In 3 cases of body and tail transplantations GL!EDMAN et al. (42) also made an 
end-to-end anastomosis of the pancreatic duct to the ureter in patients whose 
kidneys had been removed because of diabetic nephropathy. One of these 
patients still had reasonably good endocrine function after 7 months. The 
second developed leakage of the pancreas-ureter anastomosis and vascular-
suture thrombosis after the transplant had functioned adequately for 33 days; 
the graft was removed and insulin therapy reinstituted. The third patient had 
good pancreas function 10 months after the operation and no longer required 
insulin. 
5. OBJECTIVES OF PANCREAS TRANSPLANTATION 
It is evident from the foregoing that agreement has not yet been reached on the 
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ultimate influence of pancreatic duct ligation on the endocrine function. It is, 
however, clear that a mild form of pancreatitis invariably develops when liga-
tion is performed. Consequently, after performing their first human body-and-
tail transplantations with ligated duct both LILLEHEI and GLIEDMAN changed 
to a method providing for persisting enzyme outflow, the former by including 
the duodenum in the transplant and the latter by connecting tb.e duct with a 
ureter. Several serious objections can be raised to these methods: 
1. Inclusion of the duodenum means the transplantation of two organs which 
may not behave in the same way immunologically. This entails the risk of 
rejection duodenitis, as described by LILLEHEI et a!. (96) for human recipients, 
which can lead in turn to perforation of duodenum. 
2. Drainage of the pancreatic enzymes into the digestive tract, either via the 
included duodenum or via a Raux en Y shunt between the recipient's jejunum 
and the transplanted pancreas, involves intra-abdominal intestinal anastomoses 
that may become dehiscent Linder rejection processes and thus lead to peri-
tonitis, which can take a serious course due to the use of immunosuppressive 
drugs and the escape of pancreatic juices into the abdominal cavity. 
3. The establishment of an anastomosis between the pancreatic duct and a 
ureter involves the possibility of local leakage but also a much more serious 
problem, i.e., the sacrifice of a still functioning kidney, which is certainly 
contra-indicated in the severe form of diabetes mellitus that can lead to renal 
insufficiency. As a result, this operation has so far only been applied in patients 
with terminal kidney failure due to diabetes mellitus, which means that sooner 
or later a kidney transplantation will have to be performed. The main purpose 
of pancreas transplantation can, however, be expected to be the prevention of 
terminal renal insufficiency. 
4. All of the described forms of pancreas transplantation involve major, 
complicated operations for which a high morbidity can be expected, as indicated 
by the discussion of clinical pancreas transplantation. 
These objections could be eliminated by ligation of the exocrine ducts of the 
pancreas. In that case 2 vascular anastomoses situated extra peritoneally would 
suffice. Although many authors have pointed to the injurious effect of duct 
ligation on the endocrine function of the pancreas (2, 35, 87), other investi-
gators (11,66, 121, 127) have argued that there is no such effect. 
Thus, before pancreas allotransplantations with duct ligation are undertaken 
it must be known exactly what the final consequences of this ligation are for 
the endocrine function of the organ and why the above-mentioned authors 
obtained divergent results. Once the effects of duct ligation are known, separate 
investigation can be made, as far as possible, of factors originating as a result 
of allotransplantation that might also influence the endocrine function. The 
authors who claim that duct ligation has an unfavorable effect on the endocrine 
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function of the pancreas, observed the reduced function only after several 
months (74) to It years (2). This makes it necessary to follow up a number of 
allogenic pancreas transplantations over a long period. 
In studying the data in the literature concerning experimental transplanta-
tions we found a high degree of variability in the survival of the transplanted 
organs. This could be due to the use in these investigations of mainly mongrel 
dogs in which the histocompatibility between donor and recipient was unknown. 
Studies done by VRIESENDORP et a!. (141) on tte canine histocompatibility 
system and by him and others on the influence of compatibility for this system 
(tissue typing) on the survivial of heart (15), kidney (147), skin (142), and 
intestine (146) allotransplants, support our assumptions. The influence of com-
patilibility or incompatibility for the histocompatibility system on the duration 
of the survival of pancreas allotransplants had not, however, been investigated 
yet. 
If pancreas allotransplants behaved in this respect like other vascularized 
transplants, this would be an indication that there is no difference in antigenicity 
between endocrine tissue and, say, kidney tissue, as assumed by LILLEHEI & 
lDEZUKl (94). It would also mean that on the basis of tissue typing the endocrine 
function of pancreas allotransplants with ligated duct could be studied for long 
periods without the use of immunosuppressive drugs which might also have an 
influence on the endocrine function. For a reliable investigation of the possi-
bilities of allogenic pancreas transplantation with ligated exocrine ducts, there-
fore, the experimental set-up for the study described here was chosen such that 
as much information as possible could be obtained about the possible un-
favorable influence of several factors: duct ligation, ischemia, denervation, 
heterotopic localization, and rejection. 
In the following chapters a discussion will be given of a number of experi-
mental designs and experiments done in dogs in an attempt to obtain answers 
to four questions: 
I. What is the effect of ligation of the exocrine ducts of the pancreas on the 
endocrine function of the organ? 
2a. How does the endocrine function of the pancreas react ultimately after 
heterotopic pancreas autotransplantation with ligated endocrine ducts? 
2b. How does the endocrine function of the pancreas react ultimately after 
heterotopic pancreas allotransplantation with ligated endocrine ducts? 
3. What is the influence of tissue typing on the survival time of a heterotopic 
pancreas allotransplant? 
4. What is the influence of immunosuppressive drugs on the survival time 
of a heterotopic pancreas allotransplant under known tissue incompatibility 
between donor and recipient? 
CHAPTER II 
The experimental design and methods 
1. THE ANIMALS 
The dog was chosen as a suitable animal for this study on the following grounds: 
its tractability; surgically, it offers no special problems and is comparable with 
man; the availability of specially bred strains with known parentage (beagles); 
and the fact that diabetes mellitus occurs in dogs (I :152; ref. 29). 
For the experiments in which body weight and histocompatibility would not 
influence the results, use was made of mongrels not older than 5 years and 
weighing between 9 and 25 kg. These animals were obtained commercially and 
were used after a 3-week quarantine period under veterinary supervision (Cen-
tral Laboratory Animal Service, Faculty of Medicine, Erasmus University, 
Rotterdam; head: Dr. W. VAN DIJK). 
When weight or histocompatibility could have an effect, use was made of 
beagles weighing between 10 and 15 kg and aged 9 to 18 months. Some of these 
animals were obtained from the Central Institute for the Breeding of Labora-
tory Animals T.N.O. (Zeist, The Netherlands; head: Dr. J. VAN VLIET), and 
some had been bred in our own kennels. 
2. THE EXPERIMENTAL GROUPS 
In connection with the questions formulated in Chapter I, 3 experimental 
groups were formed: 
Group I: Mongrels in which both pancreatic ducts were ligated to determine 
the long-term effect of elimination of the exocrine function on the endocrine 
function of the pancreas. 
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Group 2: Mongrels given a heterotopic autotransplant with ligated ducts to 
determine whether ischemia, denervation, or the heterotopic localization would 
lead to differences in the endocrine function as compared with group l. 
Group 3: Typed beagles given a heterotopic pancreas allotransplant with 
ligated ducts. The immunological factor was included to permit evaluation of 
our method of tissue typing; to this end, the group was divided into 3 sub-
groups as follows: 
3a. unrelated, non-identical pairs 
3b. related, non-identical pairs (differing by 2 haplotypes) 
3c. related, identical pairs (0 haplotype difference) 
In addition, the influence of immunosuppressive drugs was studied in 2 sub-
groups: 
3d. related, non-identical pairs (differing by 1 haplotype) given ALS 
3e. related, non-identical pairs (differing by 1 haplotype) given azathrio-
prine and prednisone. 
3. SELECTION OF THE BEAGLES 
Prospective selection for serologically determined (SD) dog leukocyte antigens 
(DL-A) was done according to VRIESENDORP et a/. (141, 142) and WESTBROEK 
eta!. (146). Combined serological and transplant-survival experiments in small 
intestine, skin, and heart transplantations made probable the existence of a 
major histocompatibility locus in the dog (DL-A) in analogy with the HL-A 
locus demonstrated in man (I, 20). 
In these experiments use was made of the microcytotoxicity test after KISS-
MEYER-NIELSEN as modified by VAN Rooo et a/. (124). Thus, in our experi-
mental design donor-recipient combinations were prospectively selected on the 
basis of serological tests. In this study donor-recipient pairs were not tested for 
LD determinants (MLC test). 
4. TREATMENT 
Each of the 3 main groups will be discussed in a separate chapter, except for 
standardized techniques or methods used in all 3 groups, which will be dealt 
with here. For example, the surgical technique, which was different for each 
group, will be discussed in the relevant chapter. 
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4.1. Preparation for surgery 
The endocrine and exocrine function of the pancreas was checked pre-opera-
tively in all animals. In addition, the kidney function, liver function, and blood 
picture were evaluated. The dogs were not fed for 16 hours before the operation. 
On the day of the operation the administration of antibiotics was started pre-
operatively. 
4.2. Antibiotics 
Na-benzylpenicillin (Specia, Paris, France) and streptomycin sulfate (Myco-
farm, Delft, The Netherlands) were given intramuscularly in combination in a 
dosage of 2 million U penicillin and 0.5 g streptomycin twice daily. For a 
second operation, ampicillin (Penbriten, Beecham, United Kingdom) was given 
intramuscularly in a dosage of 500 mg twice daily. 
4.3. Anesthesia 
Endotracheal inhalation anesthesia was used throughout, without pre-medica-
tion. Sodium pentothal® (Abbot N.Y., Amsterdam, The Netherlands) was 
administered as preliminary anesthetic in a dose of 30 mg per kg body weight 
intravenously together with 0.5 mg atropine. Anesthesia was maintained with 
0.05 mg Fentanyl® (Janssen Farmaca, Beerse, Belgium), 6 litres N 20-02 in a 
ratio of 2:4, and fluothane (Halothane, ICI, United Kingdom). Under anes-
thesia, the following fluids were administered parentally: dextran 40 10%, 
canine plasma, glucose 5%, 0.9% Nacl, 5% NaHC03, and when necessary 
blood. The amount varied appreciably for the various groups, and will be 
discussed separately. Dextran 40 was given in connection with the favorable 
effect on the course of acute pancreatiti demonstrated by GooDHEAD (43). 
For the same reason, TrasyloJ® (Bayer) was also given (50,000 KIU intraven-
ously) during the operation, because of the reported (57, 103, 140) inhibitory 
effect on the liberated pancreatic enzymes kallikrein and trypsin. During the 
course of the study doubts arose concerning the value of this drug, which were 
reinforced by the results of new studies on its use in this situation (126). How-
ever, we continued to use it rather than change the experimental conditions 
during the study. 
During anesthesia, the pulse and an ECG were registered on an Elema 
Schonander minograph 81 and visualized on an Elema Schiinander oscilloscope 
EM 530. In a number of the experiments the arterial and venous pressures were 
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measured intravascularly at the same time and observed with the same equip-
ment. 
4.4. Post-operative treatment 
Antibiotics were administered during the first 5 days after the operation. In 
general, water was available ad lib on the first post-operative day and food on 
the second, except for pancreatectomized dogs, which were not given solid food 
until the third day. 
4.5. Diet 
Because the exocrine function of the pancreas was eliminated in these experi-
ments, special attention was given to the feeding and enzyme supplementation 
of the animals. Food was given ad lib, and dogs showing reduced appetite were 
put on a different diet. Dependent on the appearance and consistency of the 
feces and the course of the body weight, the following food was given: 
Hope Farm pellets (Hope Farms N.Y., Woerden, The Netherlands) 
Liquid diet: Wessanen* (Wessanens Koninklijke Fabrieken N.Y., Wor-
merveer, The Netherlands) 
Pelsifood (Trouw N.Y., Ermelo, The Netherlands) 
Bonzo Dinner (Bogena N.Y., Rotterdam, The Netherlands) 
Blokvlees (Bogena N.Y., Rotterdam, The Netherlands) 
Protifar (Nutricia N.Y., Zoetermeer, The Netherlands) 
Liga bisquits (Liga Fabrieken N.Y., Roosendaal, The Netherlands) 
For enzyme supplementation, a choice was made for combination among: 
Combizym compositum (Luitpold, obtained from Will Pharma, Amster-
dam, The Netherlands) 
Cotazym (Organon, Oss, The Netherlands) 
Pancreatin powders (5 g) 
Lipase capsules (25 mg) 
* This food was specially composed for our experiments by Wessanens Koninklijke Fabrieken 
(J. N. VAN HAASTER) and contained: 
Protein 20% Ash 3% 
Fat 30% lactose trace 
Moisture 5% Cal./gram 5 
Minerals and vitamins were added to an average level for feeds for omnivorous specie<;. 
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5. DETERMINATION OF PANCREAS FUNCTION 
5.1. Endocrine function 
a. Serum glucose level 
The serum glucose level was determined according to the enzymatic glucose-
oxidase method with 0-dianisidine as chromogen, as described in Standard 
Methods of Clinical Chemistry (132a). In addition to serum glucose determi-
nations made at arbitrary times, glucose tolerance tests (GTT) were performed 
at regular intervals. For these tests a loading dose of I g glucose per kg body 
weight was injected intravenously after a fasting period of at least 16 hours. 
After a fasting value had been obtained, blood samples were taken 5, 10, 20, 
and 30 minutes after the glucose injection. From the OTT values, the K value 
was calculated according to LUNDBAEK (99), this value giving the serum glucose 
disappearance rate as percentage per minute. Plotting of the OTT-derived 
values on semi-logarithmic paper gives a linear curve from which the K values 
can be calculated according to HAMILTON & STEIN (59) (see Fig. la,b for 
example). 
The K values made it possible to detect small differences in non-pathological 
blood sugar curves. LUNDBAEK found that the mean K value for normal 
human subjects amounted to 1.72%/min, and CoNARD (25,26,27) obtained a 
value of I. 74 %/min. In patients, both authors found decreasing values with 
increasing age. The highest human K values lie between 3 and 3.5%/min, the 
lowest approach zero. On this basis, CoNARD concluded that in man diabetes 
mellitus can be considered to be present at K values lying below 0.95 and can 
be excluded at values above 1.05 %/min. 0LEFSKY eta/. (I 12) put the borderline 
between normal and abnormal K values in man at 1.2 %/min. 
To obtain an impression of these values in dogs in our laboratory, we per-
formed the intravenous glucose tolerance test and calculated the K values for 
3 groups of dogs. The first group comprised 20 healthy mongrels not older 
than 5 years, the second 25 healthy beagles aged 9 to 18 months, and the third 
50 beagles and mongrels after total pancreatectomy. The mean OTT values 
and standard deviations were calculated for various time points. The following 
values and standard deviations were obtained (see Fig. la,b): for the first group 
the mean K value was 4.1 %/min ± 0.8 and for the second group 4.1 %/min 
± 1.3; K = 0 was obtained for all of the dogs of the third group. Since there 
was no difference between the mean K values for the first and second groups, 
they were combined for the determination of the distribution shown in Fig. 2. 
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Fig. I a and b. Glucose tolerance test and K value. 
a. Mean GTT value of 20 dogs, with standard deviation. K = 4.1%/min. 
b. Example of calculation vf the K value from the GTT results (see a). 
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Fig. 2. Distribution of the K Fa/ues of45 normal dogs. 
b. Serum insulin level 
I 
' 7 
The serum insulin level was determined by the radio-immunological method of 
YALOW & BERSON (150) with one modification, i,e,, the substitution of charcoal 
dextran for free and bound insulin in paper-electrophoretic separation. The 
determinations were done in the laboratory of the Department of Internal 
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Medicine Ill of the University Hospital Dijkzigt in Rotterdam. The peak insulin 
value was taken as the measure for pancreas function, i.e., the highest serum 
insulin value measured after glucose loading, which in this investigation was 
observed 5 or 10 minutes after the injection of I g glucose per kg body weight. 
The blood samples for the insulin determinations were taken at the same time 
as those for the GTT, so that the insulin secretion pattern could be evaluated if 
necessary. To obtain an impression of the normal peak insulin values in the 
dog, determinations were made in 60 healthy mongrels and beagles, chosen at 
random. The frequency distribution of these peak values proved to deviate 
distinctly from a normal (Gaussian) distribution. However, the distribution of 
the logarithmics of the peak values closely approached a normal distribution 
curve. On the basis of these data, a normal-value range of 29-199 [LV/m1 was 
found (95% variation limits). On the logarithmic scale a mean of 1.88 with a 
standard deviation of 0.21 was found. 
5.2. Exocrine function 
To evaluate the exocrine function, the fecal levels of 2 proteolytic enzymes, 
alpha-chymotrypsin and trypsin, were determined according to AMMANN (3) 
and others (52, 54) by titration. These determinations were done in the labora-
tory of the Department of Internal Medicine II (Dr. P. HORCHNER). Trypsin 
was determined at pH 8.2 at 25 'C, with Na benzoyl-L-arginine-ethylester 
(BAEE) as substrate, alpha-chymotrypsin at pH 7.8 at 25'C with N-acetyl-L-
tyrosine-ethylester (ATE£). The feces were diluted 1 :10 with a 0.9% saline 
solution and filtered. To I ml of the filtrate, 3 ml 0.05 N Tris buffer (pH 9.5) 
and 2.5 ml substrate were added. The liberated acid was titrated under N 2 with 
0.01 N NaOH, and the results expressed in international units (an international 
enzyme unit is defined as the amount of enzyme converted by a micro-mol sub-
strate per minute at 25'C). 
Here, too, the normal values and reliability were evaluated by prior determi-
nation of the enzymes in the feces of 45 healthy dogs (mongrels and beagles) 
and of 14 dogs after total pancreatectomy. The results are shown in Figs. 3 
and 4. 
In dogs with a normal exocrine pancreas function the trypsin content of the 
feces was higher than 1 IV, with a mean value of 16 IV; the alpha-chymotrypsin 
was above 1 IV, with a mean of 64 !U. After total pancreatomy both levels lay 
below 1 TV, and in 6 of the 14 dogs the alpha-chymotrypsin content was even 
nil. When a total absence of the exocrine function had to be demonstrated, a 
fat balance according to KAMER, TEN 80KKEL HUININK & WEYERS (45) was 
performed as well. 
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Fig. 3. Fecal trypsin in normal dogs and after total pancreatectomy. 
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Fig. 4. Fecal alpha-chymotrypsin in normal dogs and after total pancreatectomy. 
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5.3. Other determinations 
The amylase activity of the serum was determined according to WoHLGEMUTH 
(149). To estimate the normal values given by this method under our ex-
perimental conditions, the serum amylase level was determined in 30 normal 
mongrels and beagles and in 30 dogs which had undergone a total pancrea-
tectomy 3 days before. The value usually obtained was either 64 or 128 U, and 
in a few cases 256 U. Since with this method the values are indicated as a 
geometric progression, there is little point in showing them graphically. To 
obtain a general impression and to permit comparison of the 2 groups, the 
frequency distributions for both are shown in Fig. 5. 
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Fig. 5. Serum amylase levels in 30 dogs before (a) and after (b) pancreatectomy. 
It is evident from Fig. 5 that the values lie much higher than those obtained 
in man with the same method. There is also no difference in the amylase activity 
before and after pancreatectomy. According to ETD eta/. (40), in the dog iso-
enzymes are measured that do not occur in man, which explains the higher 
levels as well as the absence of a change after pancreatectomy. 
The serum sodium level was determined flamphotomectrically with a 
Beckman fiamphotometer, which showed normal values of 3.3-5.8 mmol/litre, 
with a coefficient of variation of± 4%. 
The serum bilirubin level determined according to JENDRASSOK-GRAFT (132c) 
gave normal values of I. 7-9.5 mmol/litre, coefficient of variation ± 5%. 
32 TRANSPLANTATION OF DUCT-LIGATED PANCREAS 
Serum alkaline phosphatase was measured according to BESSEY eta/. (132b) 
with dinatrium-p-nitrophenyl-phosphate as substrate, the glycerine buffer at 
pH 10.5, and the reaction temperature 37°C. Normal values 8-50 IUjlitre 
(BESSEY), coefficient of variation ± 5%. 
Serum calcium was determined by titration with EDTA and Murexide® as 
indicator. Normal values: 2.30-3.00 mmol/litre, coefficient of variation: ± 3%. 
Serum magnesium was determined in the same way as serum calcium but 
with Ericom T as indicator. Normal values: 0.50-1.32 mmol/litres, coefficient 
of variation: ± 5%. 
Serum creatinine was determined by the Jaffe reaction after adsorption to 
frankonite according to GORTER & DE GRAAF (44). Normal values: 40-90 
mmol/litre, coefficient of variation: ± 5%-
The hemoglobin content was measured according to the HiCN method of 
the Netherlands Institute for Public Health. Normal values: 13.8-14.7 g %, 
coefficient of variation: ± 3 %. 
The blood gas values were determined with an AstrUp micro instrument type 
A.M.E.I.c. (Radiometer, Copenhagen, Denmark). 
6. PATHOLOGICAL ANATOMY 
An autopsy was performed on all dogs which died or were killed. The micro-
scopical investigation was performed by Dr. I. MACDICKEN (Laboratory for 
Experimental Surgery of Erasmus University). Tissue was fixed in buffered 
neutral formalin 4% (pH 6.8) for at least 24 hours, embedded in paraffin, cut 
into 4-5 fL sections, and stained with hematoxylin-azophloxine-saffron (HAS). 
When the presence of beta-cell granules remained uncertain after this staining, 
use was made of aldehyde fuchsin staining according to GOMORI (42a). 
CHAPTER lil 
Ligation of the pancreatic duct 
1. INTRODUCTION 
The divergence of the reported results on the effect of ligation of the exocrine 
outflow of the pancreas on the endocrine function of the organ has already 
been mentioned in Chapter I. Because of these differences and the fact that 
some of the results are not convincing, it was considered necessary to determine 
the influence of ligation on the function of the pancreas before performing 
pancreas transplantations with ligation of the exocrine ducts. It seemed possi-
ble, for one thing, that the gradual deterioration of the endocrine function after 
the heterotopic allotransplantation of a pancreas with ligated duct is due to 
beta cell degeneration rather than to chronic rejection phenomena. 
On this basis it seemed worthwhile to start by ligating the exocrine ducts in 
a number of animals and following the endocrine function for an extended 
period. For a study of this kind, the following criteria had to be satisfied: 
I. Use of the same species as for pancreas transplantation. 
2. Evaluation of the exocrine function, which should be completely abolished 
after ligation. 
3. Periodic evaluation of the endocrine function. 
4. Histological investigation at various intervals after ligation. 
5. Prolonged follow-up. 
2. MATERIAL AND METHODS 
Sixteen mongrel dogs were operated on via an incision in the upper abdomen 
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under endotracheal anesthesia and aseptic conditions. The pancreas was dis-
sected from the duodenum as described MARKOWITZ et a/. (102), leaving the 
vasularization intact. Both pancreatic ducts were identified, cut, and both 
ends tied off. The duodenum was wrapped in a flap of omentum such that the 
pancreas and duodenum were securely separated, after which the abdomen was 
closed in 2 layers with tied silk sutures. 
In connection with the reduced vascularization of the duodenum, the animals 
were not allowed to drink ad lib until the third day; until then, fluid was sup-
plied by hypodermoclysis in the form of a 0.9% saline solution. On the third 
day, solid food supplemented with pancreatic enzymes was given; thereafter, 
the diet was adapted to the needs of the individual animals. The administration of 
pancreatic enzymes was based on the consistency of the feces and the body 
weight. 
The animals were evaluated pre-operatively and a week, a month, 5 months, 
a year, ll years, and 2 years post-operatively. The evaluation consisted of an 
intravenous glucose tolerance test, from which the K value was calculated, and 
determination of the insulin peak values (IPV). Furthermore, at each check the 
liver and kidney functions, the serum Ca and Mg levels, and the amylase con-
tent of the serum were determined as well as, at entirely random times, the 
non-fasting serum glucose level. The checks at the above-mentioned intervals 
included determination of the proteolytic enzymes trypsin and alpha-chymo-
trypsin in the feces, which were only sampled after the supplementary pancreatic 
enzymes had been withheld for at least 5 days. At regular intervals, an animal 
was killed for histological investigation of the pancreas. 
The techniques, materials, and laboratory determinations have been deM 
scribed in Chapter II. 
3. RESULTS 
Of the 16 dogs, 3 died shortly after the operation. One of these died on the 
first post-operative day; the autopsy results indicated only the onset of pan-
creatitis. The second animal died on the 12th post-operative day of pneumonia, 
and the third on the 17th day of a duodenal perforation. 
The remaining 13 dogs could be followed for 2 years except those used for 
the histological studies. The dogs maintained a satisfactory weight on a daily 
dose of I tablet Combizym and !J tablet Cotazym per kg body weight. 
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3.1. Exocrine function 
The exocrine function was supposed to be nil, in other words equal to that of 
totally pancreatectomized animals. Therefore, as mentioned in Chapter II, the 
proteolytic enzymes in the feces were determined and compared with the norms 
after total pancreatectomy. The results are shown in Table I, from which it is 
TABLE! 
Trypsin (IU) a; chymotrypsin (IU) 
Nr. pre-op. 4 weeks 24 weeks pre-op. 4 weeks 24 weeks 
post-op. post-op. post-op. post-op. 
~-----·-- "~----··--
"--"" _____ 
""-----~-" --
452 0"8 0.2 0.4 0"5 
481 15" I 0"8 0"3 12.4 0"4 0 
477 8"2 0"5 0"6 0 0"3 0 
465 10"3 0.4 0"8 12 0.4 0"4 
476 8"8 2"5 1"9 224 11.3 3"9 
502 6"8 0"3 1.2 19 0 0"4 
493 9"7 0.4 0"5 89 0"1 0"6 
583 6"0 0"7 0"5 43 0 0 
588 4"5 1"9 1"2 88 20"0 13 
613 30"3 9 1"8 145 51 8"9 
766 43 0"5 0.4 77 0"5 0"7 
892 7"8 0 1.0 9 0"3 0 
899 7"5 0"5 0 68 0 0 
-------·-~ "--------""" ~----.-~-- "~------
evident that 3 dogs (nrs" 476, 588, and 613) did not satisfy the norms, because 
some endocrine function persisted. The enzyme levels of these 3 dogs are shown 
in italics" The endocrine function of these dogs was not followed further. 
Thus, 10 dogs remained available for the study" Of these, 6 could be followed 
for 2 years. At the end of this time the exocrine function, as determined on the 
basis of the 2 proteolytic enzymes in the feces, was still nil. 
3"2" Endocrine function 
Table II shows the K value and insulin peak values for the 10 dogs followed 
post-operatively for 2 years or until killed" The first post-operative K value of 
dog nr" 493, as well as the K and insulin peak values of nr. 583 after It years, 
are lacking because the blood samples were lost" 
Among the first post-operative K values, the abnormally high 6"5%/min for 
dog 583 is striking" Nevertheless, this value corresponds well with the insulin 
peak value of 180 fLU jml. 
In Figs" 6 and 7 these values and the means are shown graphically, and Fig" 8 
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TABLE II 
K values and insulin peak values before and at various times after pancreatic duct ligation. 
--------- ~~-'-·~---
Dog Pre-op. 1 week 5 weeks 20 weeks 1 yr. lj- yr. 2 yr. 
nr. post-op. post-op. post-op. post-op. post-op. post-op. 
K insulin K insulin K insulin K insulin K insulin K insulin K insulin 
%1 ~U/ %! ~U/ %1 I"U/ %1 I"U/ %1 ~U/ %1 tJ.U/ %1 ~U/ 
min ml minml min ml minml minml minml min ml 
. ·------------
452 3.5 73 3.5 108 2.2 15 4.1 24 
477 3.9 49 4.6 26 2.5 8 3.9 16 
481 4.6 180 2.0 18 2.8 20 1.9 34 4.6 48 3.0 51 3.9 67 
465 5.3 57 2.0 30 2.7 29 2.0 14 2.4 9 3.8 26 
502 4.6 91 2.3 56 2.3 34 2.0 49 3.5 58 3.2 39 2.3 103 
493 5.8 83 66 4.6 115 2.1 10 5.3 55 
583 4.6 6.5 ISO 3.8 97 2.8 73 2.3 46 2.0 33 
766 3.8 140 3.8 130 3.8 80 2.3 58 3.3 91 3.8 240 2.2 115 
892 4.6 240 3.9 126 2.0 64 3.0 57 2.2 104 3.9 56 2.3 39 
899 3.0 100 2.0 77 2.5 59 2.0 30 2.8 75 2.0 37 4.1 64 
------------- ------·--·· 
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Fig. 7. Insulin peak values before and after pancreatic duct ligation. 
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Fig. 8. The course of endocrine fuw:tion after duct ligation in 6 dogs over a period of 2 years. 
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gives the average course in 6 dogs followed for 2 full years. Here, the pre-
operative values were taken as 100 per cent. The values for the non-fasting 
blood sugar level did not exceed 100 mg% at any time. 
3.3. Other determinations 
A slight elevation of the alkaline phosphatase level (90 Ujlitre Bessey) was ob-
served only once, in the first week after the operation. Throughout the entire 
period of observation none of the dogs showed any other anomalous changes 
in either the bilirubin or alkaline phosphatase levels. All of the animals showed 
significant increases in the amylase content during the first post-operative week, 
the highest values occurring on the third day and amounting on average to 
2048 U. After that, the amylase values returned to normaL 
There were wide variations within dogs, but elevated values were not seen 
after the !3th post-operative day. The creatinine, Ca, and Mg levels remained 
normal throughout, and the same holds for the hemoglobin level and the 
morphological blood picture. 
3.4. Pathological anatomy 
Table III shows the data for the autopsied animals. Macroscopically, little of 
the original pancreas could be found, usually not more than some pinkish 
fibrotic strands (Plate 1). The presence of adhesions made these strands difficult 
to find, however, and in a few cases (e.g. dog nr. 493) no pancreas tissue at all 
could be demonstrated in the biopsy samples. 
Microscopical examination revealed disappearance of acinar tissue, which 
had been replaced by connective tissue in which nests of islet tissue could be 
found (Plate 3). This change could be observed as early as the 12th and 16th 
days when, remarkably enough, there had been hardly any signs of pancreatitis. 
In the dogs (nrs. 588, 476, 613) which still showed enzyme activity, distinct 
acinar tissue could be seen. 
4. DISCUSSION 
The body weight of the 10 dogs increased by 2 to 3 kg in the 2 years during 
which they were observed. The pancreatic enzyme preparations Combizym and 
Cotazym (I and I tablet per kg body weight, respectively) were given to main-
tain a good general condition. 
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TABLE III 
Data on dogs with ligated pancreatic ducts (available for histological investigation), in order 
of duration of survival. 
Dog 
nr. 
529 
850 
978 
588 
452 
477 
476 
493 
613 
465 
418 
Trypsin 
& "-
chymo-
trypsin* 
t 
t 
-r 
+ 
Cause of 
death 
Pancreatitis 
Pneumonia 
Duodenal 
perforation 
Killed 
Killed 
Killed 
Killed 
Killed 
Killed 
Killed 
Killed 
Time 
post-op. 
(in days) 
12 
16 
167 
181 
218** 
245 
329 
716 
716 
884 
Histological findings 
Early stage hemorrhagic pancreatitis 
Extensive fibrosis with loss of acinar 
tissue. Islets distinctly present. No signs 
of pancreatitis. 
Fibrosis. Few signs of pancreatitis 
Marked loss of acinar tissue. Capsular 
peritonitis. Islets easily recognizable. 
Some sections show normal pancreas 
tissue, others atrophic acinar tissue 
with dilatated ducts. No signs of pan-
creatitis. Extensive areas of fibrosis con-
taining islet tissue with beta cell gra-
nules. 
In all sections extensive fibrotic areas 
with only islet tissue remaining. No 
signs of pancreatitis. 
Marked fibrosis with islet tissue and 
remnants of atrophied acini. Peri ductal 
fibrosis. No signs of pancreatitis. 
Marked fibrosis; islet tissue present. 
Some lobe sections show only partiaily 
atrophied acinar tissue. No signs of 
pancreatitis. 
No pancreas tissue demonstrable in 
any of the sections. 
Total fibroid degeneration; some acinar 
tissue intact but islet tissue predomi-
nating. No signs of pancreatitis. 
Total fibrotic degeneration of acinar 
tissue; islet tissue distinct and showing 
beta cell granules. No signs of pan-
creatitis. 
Total fibroid degeneration of the acinar 
tissue, in which islet cells and beta cell 
granules can be distinguished. No signs 
of pancreatitis. 
* Symbols: t = died before enzyme determinations could be made. 
+ = persisting enzyme activity. 
- = no enzyme activity. 
** See Plates I and 3. 
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It is clear that the surgical technique applied did not lead to complete aboli-
tion of the exocrine function of the pancreas in all cases. Thus, a reliable check 
on this point is indispensable; for this, the determination of the proteolytic 
enzymes trypsin and alpha-chymotrypsin in the feces proved to be an adequate 
method. In the cases in which enzyme activity could still be demonstrated in 
the feces, the histological investigation showed the presence of intact acinar 
tissue. 
The persistence of exocrine pancreas function despite ligation of both ducts 
could be due to one of four possibilities: a) regeneration of exocrine tissue 
(LEHV & FITZGERALD, ref. 89); b) perforation of a pancreacyst in the duode-
num; c) existence of aberrant pancreatic ducts; d) existence of aberrant pan-
creatic tissue elsewhere (84, 94). 
In the dogs with a limited persisting exocrine function we invariably found 
intact acinar tissue near the duodenum, just distal to the pylorus. This would 
argue for point c, the presence of aberrant ducts. Regeneration (point a) is 
unlikely, because none of the dogs lacking the exocrine function immediately 
after the operation regained this function during the 2-year observation period. 
Duodenal perforation (point b) seems excluded, because no signs were found 
histologically. Point d is in conflict with the consistent observation of acinar 
cells in, and not outside, the pancreas in the dogs with persisting exocrine 
function, whereas no acinar tissue was demonstrated in the dogs lacking this 
function. 
The course of the endocrine function of the other animals showed an initial 
gradual decrease to 50 per cent of the original K value of the intravenous GTT 
and to 35 per cent of the original insulin peak value. After the 20th week, how-
ever, both values began to rise, the K value reaching 75 per cent of the original 
value and the IPV 60 per cent. But it must be kept in mind here that one dog 
showed an abnormally high value for the first post-operative determination, 
i.e., a K value of 6.5 with an IPV of 180 fLU/ml. If this had not occurred, the 
total picture would be quite different: a drop in the endocrine function immedi-
ately after the operation and partial recovery starting after the 20th week. 
Nevertheless, even in the period of poor endocrine function, no pathological 
blood sugar values were found, even directly after a meal. 
These findings are in agreement with those of authors (4,22, 121, 127) who 
did not see diabetes mellitus after duct ligation. HIEBERT eta/. (66) and MACK 
et al. (100) even found no reduction of the endocrine function. We saw an 
initial diminishment of this function, like those authors (2, 35, 74) who found 
lower insulin excretion and lower K values after ligation, but we did not see a 
single case of diabetes mellitus. On the contrary, the endocrine function im-
proved after some time in our series. An explanation for these conflicting find-
ings must be sought, in our opinion, in the possibility of hypertrophy and 
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regeneration of islet cells, as described by LOGOTHETOPOULOUS (97), which 
indicates that in cases of pancreas damage the diet and the serum glucose level 
can influence beta cell degeneration and regeneration. Furthermore, inadequate 
supplementation of pancreatic enzymes after abolition of the exocrine function 
leads to a reduction of glucose resorption from the digestive tract (138), which 
in turn can lead to beta cell degeneration. Thus, the proper supplementation 
of pancreatic enzymes is of great importance. 
The persistence of normal serum Ca and Mg levels and liver function con-
firms the findings of ANLYAN eta/. (4). The pancreatitis was not sufficiently 
severe to depress the calcium level in the serum as described by EDMONDSOI\' 
eta/. (38,39). Pancreatitis can be demonstrated both histologically and bio-
chemically. The important factor here is that histological investigation shows 
that the acinar tissue disappears and is replaced by connective tissue, whereas 
the islets remain completely intact. 
5. CONCLUSlONS 
From the foregoing, it is evident that in experimental auto- or allotransplan-
tations of a pancreas with ligated ducts in dogs, the following aspects must be 
taken into account: 
I. Aberrant pancreatic tissue may be present. This must be checked in the 
pancreatectomized recipient, because otherwise the hormone determinations 
may be incorrectly interpreted. A reliable method is provided by determination 
of the proteolytic enzymes in the feces. 
2. A recipient lacking exocrine pancreas function should receive at least 
I tablet Combizym and t tablet Cotazym per kg body weight, or the equivalent, 
to maintain metabolic balance. 
3. During the first 2 weeks after transplantation a mild pancreatitis develops 
which is most severe during the first 5 post-operative days. 
4. Immediately after the operation a sharp drop in the endocrine function 
can occur without the development of diabetes mellitus. This endocrine func-
tion gradually improves and can possibly be influenced by a carbohydrate-rich 
diet combinet with an excess of pancreatic enzymes. 
CHAPTER IV 
Autotransplantation of the pancreas with 
ligated ducts 
1. INTRODUCTION 
Once the effect of ligation of the exocrine outflow on the endocrine function of 
the pancreas was known, other potentially negative factors such as ischemia, 
denervation, heterotopic localization, and immunological rejection phenomena 
(in combination with duct ligation)remained to be investigated. Heterotopic auto-
transp Iantation of the pancreas offered a good model for the studyte the first 3 of 
these factors,since immunological effects areexcl uded. If the results proved to differ 
from those obtained with duct ligation alone (see Chapter III),an attempt could be 
made to determine which of the three factors was responsible and to what degree. 
Unfortunately, autotransplantation of the whole pancreas involves difficult 
technical problems for the surgeon, because the organ is supplied with blood 
by 3 arteries (see Fig. 9): the splenic artery, the inferior pancreaticoduodenal 
artery, which arises from the superior mesenteric artery, and the superior pan-
creaticoduodenal artery, which arises from the gastroduodenal artery. The 
venous vascularization is analogous to the arterial as far as the junction with 
the portal vein. Because the donor is also the recipient, the pancreas must be 
removed without damage to other organs. This means that the blood vessels 
must be cut close to the pancreas, which in principle would require 6 small 
anastomoses. In some cases, however, the entire pancreas is supplied via the 
central vessel, the superior pancreaticoduodenal artery. A case of this kind is 
shown in Plate 23, a radiogram made after the injection of a contrast medium 
consisting of a barium suspension (Micropaque®, Nicholas B.V., Amsterdam, 
The Netherlands). In such cases the transplantation requires only one arterial 
anastomosis (for the superior pancreaticoduodenal artery) and one venous 
anastomosis (for the gastroduodenal vein). 
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Fif{. 9. Schematic representation of the arterial blood vessels supplying the canine pancreas. 
UcHIDA eta/. (139) performed this kind of autotransplantation in dogs, but 
with inclusion of the duodenum. In a number of cases small areas at both ends 
of the pancreas became necrotic. Five of the 15 animals survived for 4 to 12 
months. The blood glucose values differed little from the pre-operative levels. 
Nevertheless, pancreatitis developed even though the exocrine ducts had not 
been ligated. 
GRENIER eta/. (48) performed auto transplantations of the tail of the pancreas 
to the neck in 13 dogs. The transplant functioned in only 6 of the dogs, the 
longest duration being 26 days. With the technique applied, the pancreatic duct 
was cannulated. 
MITCHELL & DAVIDSON (109) described canine autotransplantations of the 
tail of the pancreas, with ligated duct, to the groin. Two of the 20 transplants 
continued to function until the fifth and sixth months. 
MURAT et a/. (I II) performed autologous transplantation of the entire 
pancreas, with ligated ducts, to the fossa iliaca. One of the 12 dogs did not 
required insulin over a period of 13 months. 
DREILING & ASHIKARI (36) performed auto- and allotransplantations to the 
neck with sacrifice of the uncinate process. The exocrine function was main-
tained intact by inclusion of the duodenum or cannulation of the pancreatic 
duct. For these 40 dogs the authors reported a transplant survival time of 
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1 to 18 months, the most important observation being marked deterioration 
of the exocrine function while the endocrine function remained good. 
BEAVEN eta!. (8) used merino sheep for pancreas-tail autotransplantations 
to the neck 2 to 3 months after ligation of the pancreatic duct. Four of the 
animals could be followed for 9 months. After loading with glucose and tol-
butamide, insulin production was good, and histological investigation after 
9 months showed that functioning islets were still present. 
It is therefore evident from the literature that regardless of the technique 
applied, the percentage of successful pancreas autotransplantations, whether 
with or without ligation of the duct, has been low. When technical compbca-
tions did not occur and the transplant functioned well, however, the GTT 
values and the serum insulin levels measured in the peripheral blood were rough-
ly the same as those found pre-operatively. In general, adequate endocrine 
function was observed after autotransplantation of part of the pancreas, but 
this function gradually dwindled and eventually disappeared. Only with trans-
plantation of the whole organ (Ill, 139) was prolonged endocrine function 
obtained. 
In view of the important information that a pancreas autotransplantation can 
provide, we thought that it would be useful for the present study to attempt 
transplantation of the whole organ with ligation of the exocrine ducts in a 
number of dogs. 
2. MATERIAL AND METHODS 
Under the conditions described in Chapter II, the operation was performed in 
17 dogs (mongrels). The pancreas was dissected from the duodenum according 
to MARKOWITZ eta!. (102), and both ducts were found, cut, and ligated. The 
inferior pancreaticoduodenal artery and vein were ligated, as well as the branch 
or branches of the splenic artery and vein. The superior pancreaticoduodenal 
artery was tied off at the origin from the gastroduodenal and was cannulated 
distally to permit flushing of the pancreas with about 200 ml of a 500 ml 
physiological saline solution (4-IOoC) containing 25 mg heparin 2% and 50 ml 
procaine HCI 2%. The gastroduodenal vein was detached from the portal vein. 
After completion of the flushing, the blood vessels were sutured end-to-side 
with 6 x 0 silk to the right iliac vessels or to the aorta and caval vein below the 
renal arteries. After revascularization, any non-vital parts of the pancreas were 
removed. 
During the operation, 25,000 KIU Trasylol was administered, and post-
operatively 50,000 KIU was given daily for 5 days. Nothing was given orally 
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on the first 2 post-operative days, 1500-2000 ml fluid being administered pa-
rentally. If the dogs drank adequately on the third post-operative day, solid 
food was given on the fourth day, supplemented with pancreatic enzymes. 
Insulin was not given at any time. 
All function tests and routine determination were performed as described 
in Chapter II. Body weight was measured regularly. All dogs which died or 
were killed were autopsied and the pancreas investigated histologically. 
3. RESULTS 
All but one dog (nr. 16) required resection of part of the pancreas (tail or 
uncinate process or both) due to an inadequate blood supply. The other parts 
of the pancreas acquired a good pink color immediately after revascularization. 
Extensive intracapsular edema developed rather quickly in all cases. As could 
be expected, the results were poor. Most of the animals died shortly after the 
operation. 
To facilitate discussion of the results, the animals can be divided into 2 
groups, one comprising the dogs which died during the first 5 post-operative 
days and the other those which survived longer. 
3.1. Dogs with a survival time of less than six days 
Ten dogs died before the sixth post-operative day. The relevant data are shown 
in Table IVa. 
The only pancreas which functioned demonstrably was the autotransplant 
of nr. 238. On the first 2 post-operative days the blood glucose values fluctuated 
between 30 and 40 mg %. Our later experience with allotransplantations (see 
below) showed that hypoglycemia occurs after transplantation, and although 
objective evidence is lacking it seems certain that this animal died of hypo-
glycemia. 
The cause of death in the other animals requires no discussion. In 6, throm-
bosis of the anastomoses was found. All but one dog had severe pancreatitis, 
the exception being nr. 238, in which the transplant functioned. It is also note-
worthy that in nr. 83, in which thrombosis did not develop, signs of the onset 
of fibrosis with disappearance of acinar tissue were present after 5 days. 
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TABLE IVa 
Results in dogs with a survival time of less than 6 days. 
Dog 
nr. 
Survival Function Clinical Post-mortem findings 
(days) transplant* cause of death 
83 5 
181 2 
238 2 
283 2 
300 
316 3 
646 5 
627 3 
!88 
608 4 
* + = present. 
- = absent 
Perf. duodenum Perforation peritonitis. Slight fibrosis of 
acinar tissue. Blood vessels normal. 
Hypercalcemia Arterial thrombosis in anastomosis ac-
assoc. with companied by extensive ischemic ne-
peritonitis 
Pancreatitis, 
possible 
hypoglycemia 
Unknown 
Ventricular 
fibrillation 
crasis. 
Pancreas almost normal with some 
signs of peripheral inflammation. 
Autolytic pancreatitis with total throm-
botic occlusion of the anastomoses. 
Onset of sludging in anastomoses. Mild 
ischemic pancreatitis. 
Pancreatitis Extensive hemorrhagic pancreatitis. No 
thrombosis. 
Hyperglycemia Extensive pancreatitis with thrombosis 
in anastomoses. 
Hyperglycemia Advanced autodigestion of the pan-
creas. No signs of thrombosis. 
Unknown 
Pneumonia 
Thrombosis in all vessels with total 
autolysis of the pancreas. 
Pancreas: autodigestion, necrosis, mo-
nonuclear ceil infiltration, venous con-
gestion. Thrombosis in venous anasto-
mosis. Lungs: pneumonia. 
3.2. Dogs with a survival time longer than six days 
The data for these dogs is shown in Table IVb. In this group several of the 
transplants functioned. The criterion for function was an upper limit of80 mg% 
for blood sugars on the first 2 days after the operation despite the parenteral 
administration of glucose. 
In the dogs which lived longer than 10 days, the proteolytic enzymes in the 
feces were determined. All values lay below I U. 
Histologically, this material too showed extensive signs of pancreatitis, 
numerous venous thromboses, and complete fibrosis of the acinar tissue. 
AUTOTRANSPLANTATION OF THE PANCREAS WITH LIGATED DUCTS 47 
TABLE1Vb 
Results in dogs with a survival time of more than 6 days. 
Dog Survival Function Clinical Post-mortem findings 
nr. (days) transplanr"" cause of death 
16 1.825 Killed 
31 55 + Jaundice 
99 10 Ligated 
choledochus 
duct 
229 135 + Killed 
263 7 Killed 
474 50 Killed 
536 16 -, Killed 
-= present. 
- = absent. 
3.3. Endocrine function 
Pancreas: Complete disappearance of 
acinar tissue. Extensive areas of fibrosis 
containing islets of Langerhans. B cell 
granules recognizable. Aldehyde fuchsin 
staining: alpha and beta cells and B cell 
granules distinguishable. 
Distinct biliary congestion of extra-
hepatic origin. Fibrosis of hepatic portal. 
Pancreas: completely fibrotic; no islet 
tissue found. 
Extensive venous thrombosis with edema-
tous pancreatitis. Liver: Many polynu-
clear cells; biliary stasis. Mild cholangitis. 
Pancreas: Complete fibrotic replacement 
of acinar tissue, in which normal islets 
present. 
Severe destructive pancreatitis; autodi-
gestion. No signs of thrombosis. 
Pancreas: fibroid replacement of all acinar 
tissue. No islet tissue recognizable. 
Advanced digestion of pancreas and mo-
nonuclear cell infiltration. Fibrosis of 
acinar tissue. Hemorrhagic pancreatitis. 
No signs of thrombosis. 
The data on the 6 dogs with post-operative pancreas function are shown in 
Table V (these are the dogs indicated by a plus sign in the third column of 
Tables IVa and lVb). The second column of Table V shows the length of time 
that the transplant functioned, not the survival time of the animal. 
In the 3 dogs in which the organ functioned for only I or 2 days the K value 
and IPV could not be determined, and therefore the highest blood glucose value 
measured on the first post-operative day is given in the third column of Table V. 
The fourth column shows the first post-operative K value and the fifth the 
corresponding insulin peak value, from which it is evident that only two of the 
transplants functioned for more than a very brief period. 
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TABLE V 
Endocrine function in autotransp/ants. 
Dog Duration Highest K value IPV 
nr. of blood %/min. ([LU/ml) 
transplant glucose 
function level on 
(days) 1st post-
op. day 
(mg%) 
-------
16 1,825 50 1.7 65 
31 1 71 
229 57 50 2.4 20 
238 2 40 
474 I 76 
536 5 60 2.6 39 
----
The endocrine function of dog nr. 229 decreased gradually; 57 days after the 
transplantation the blood sugar values rose to more than 120 mg % and the 
K value approached zero. The animal began to lose weight and to drink 
copiously, suggesting diabetes mellitus. This dog could be kept in good con-
dition for some time by the administration of tolbutamide, and was finally 
killed on the !33th post-operative day for histological investigation. 
Dog nr. 16 showed a very different picture, since the endocrine function 
improved. After exactly 5 years, this dog was killed for histological investiga-
tion. The post-operative course in this animal requires separate discussion. 
3.4. Dog nr. 16 
This is the only dog in which it did not prove necessary to excise a non-vital 
part of the pancreas after revascularization. This pancreas, which was anasto-
mosed to the aorta and the caval vein below the renal vessels, was completely 
viable. The endocrine function was poor immediately after the operation but 
gradually improved. Fig. 10 shows the 5-year course of the K and IP values 
graphically; the former are normal and the latter just barely normaL 
Because in this case it was important to know whether aberrant pancreatic 
tissue was present or regeneration had occurred, the proteolytic enzymes in the 
feces were determined twice in succession a year after the operation. The first 
determination showed 0.4 IU trypsin and 0.0 alpha-chymotrypsin, the second 
gave 0.3 IU and 0.0, respectively. In addition, a fat balance was performed. 
The resorption coefficient was zero, and the same result was obtained 6 months 
later. 
After 3 years a laparatomy was performed to explore for aberrant pancreas 
AUTOTRANSPLANTATION OF THE PANCREAS WITH LIGATED DUCTS 49 
Kvalue (%min) 
4 
3 
2 
~ f( value of GTT 
f-- -1 Insulin peck value 
A 
' ' 
Insulin 
,uU/ml 
250 
200 
----<150 
' ' I ' 100 
' ' 
.. ' ' ...... ---------
___ ... ·-------- -------- .... ----- 50 
_..--
/ 
0 2 4 l2 l8 24 30 36 42 48 54 60 
months post-op. 
Fig. 10. Endocrine jlmcti(!n of a pancreas autotransplant with ligated ducts over a period of 
5years (dognr./6). 
tissue, and samples of the connective tissue around the duodenum were taken. 
No pancreas tissue was found. 
The exocrine function could be adequately supplemented with I tablet Com-
bizym and ~tablet Cotazym per kg body weight daily, and the animal remained 
in good condition. The stool was voluminous. Over the 5-year period the body 
weight increased by 4 kg. Determination of the fecal proteolytic enzymes after 
4 and 5 years showed no signs of exocrine activity. 
Five years after the autotransplantation the organ was removed per lap-
aratomy (Plate 4) and a thorough search for aberrant pancreas tissue was made 
(Plate 4a), but none was found. 
Histological findings: The entire pancreas showed fibroid degeneration. No 
acinar tissue could be distinguished. Islets lay in the connective tissue (see 
Plate 5). With aldehyde fuchsin staining the alpha and beta cells could be 
distinguished and beta cell granules identified (Plate 6). The biopsy samples 
from the duodenum showed no pancreas tissue. The liver tissue was normal. 
It may also be mentioned for this dog that the amylase values were strongly 
elevated during the first 14 post-operative days but after that never rose above 
128 U. The liver function and serum Ca and Mg values remained normal 
throughout the 5-year period. 
4. DISCUSSION 
When a total pancreatectomy after MARKOWJTZ et al. (102) is performed in the 
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dog, the duodenum is disturbed as little as possible. Since the pancreas is to be 
removed, it need not be handled with special care. The reverse holds for an 
allotransplantation, in which the donor is sacrificed: in the course of the dis-
section the serosa of the duodenum is often severely damaged but the capsule 
of the pancreas is left completely intact. For an autotransplantation, both 
organs must remain in good condition. This is difficult to achieve, however, 
and both the pancreas and the duodenum are sometimes damaged. The reaction 
of the pancreas to such lesions may lead to pancreatitis, and duodenal per-
foration can result from local disturbance of the vascularization of the duo-
denum. 
Another source of pancreatic lesions is related to the fact that the blood 
supply to the pancreas is provided by 3 arteries, only one of which can be used 
at transplantation, i.e., the gastroduodenal artery. As a consequence of this, 
after revascularization part of the tail and the uncinate process of the pancreas 
may no longer be viable and must be excised. In our series the vascularization 
after re-implantation was only sufficient to supply the entire pancreas in one 
case (nr. 16). The fact that this dog also had the longest survival time cannot 
be taken as an indication of a causal relationship in this limited material, but 
it is in agreement with the reports in the literature (see page 43). 
Furthermore, with the autotransplantation technique the anastomoses of the 
gastroduodenal artery and vein are narrow, which can promote the develop-
ment of thromboses. In addition, the pancreatitis leads to a considerable rise 
in the hematocrit value. In one of the dogs the hemoglobin level rose from 14 g 
% to 22 g % despite the administration of I 500 ml fluid. This means a change 
in the viscosity of the blood, which also promotes thrombosis. All these factors 
may explain the finding of thromboses at one of the 2 sutures in 7 of the dogs. 
In a number of cases the lack of, or very poor, transplant function must be 
assumed to have been caused by the very severe pancreatitis in the absence of 
thrombotic phenomena. 
Two dogs died of a hepatic anomaly due to obstructive jaundice. Nr. 99 had 
an obstruction of the choledochus duct due to a hemostatic ligature, and nr. 31 
proved to have a histologically normal liver with swollen biliary ducts. Although 
the choledochus duct could be catheterized easily from the duodenum and 
proved to be patent, the extensive fibrosis in the area of the hepatic portal 
could have been responsible for the congestion seen in the liver. 
With respect to the transplants that functioned, it is noteworthy that the 
endocrine function was low post-operatively, although the blood sugar values 
were normal in this period. 
The K and insulin peak values of dogs 229 and 16 were determined on the 
42nd post-operative day, those of nr. 536 on the 3rd day after the operation. 
No explanation can be offered for the functional failure in nr. 229, but the 
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gradual deterioration resembles the findings of MITCHELL & DAVIDSON (109) 
and GRENIER et a/. ( 48). 
In comparison with the group of dogs discussed in Chapter III, the signs of 
pancreatitis were more pronounced in this group, both clinically and morph-
ologically. The loss of endocrine function was appreciably greater, certainly 
with respect to insulin secretion. It is conceivable that this loss of function was 
due to the severe pancreatitis caused not only by traumatic damage but probably 
also by an inadequate blood supply and venous congestion, as described by 
TEIXEIRA & BERGAN (136). 
In the only dog with a long survival time, however, we saw within a year a 
considerable recovery of the endocrine function, the K value reaching 4.2 %/ 
min. The insulin peak value lagged slightly, as was also the case for the ligated 
group. The possibility of a vagotomy effect must be taken into consideration 
here (see Chapter I, section B.4). Another factor which might explain the 
slightly lowered insulin values is the absence of the exocrine function of the 
pancreas, since insufficient glucose resorption from the digestive tract can lead 
to hypofunction of the endocrine system of the pancreas due to a deficiency of 
alpha-amylase. 
5. CONCLUSIONS 
In the dog, heterotopic autotransplantation of the entire pancreas or of a large 
part of the organ with ligated ducts, is usually accompanied by severe lesions 
incurred by both the pancreas and duodenum during dissection. This damage 
and the poor blood supply (see above) after autotransplantation can result in 
severe pancreatitis and thromboses in the vascular anastomoses. These factors 
can lead to total elimination of the endocrine function of the pancreas. 
When the lesions incurred by the pancreas are not severe, the endocrine 
function can be recovered. The fact that this happened in one case shows that 
the method itself is adequate if good vascularization of the pancreas can be 
guaranteed and severe traumas and thrombosis of the anastomoses can be 
avoided. 
The effects of heterotopic localization and of denervation are not clear, but 
in any case these factors do not have such a strong influence that they can lead 
to abnormality of the ultimate endocrine function of the pancreas. 
CHAPTER V 
Allotransplantations 
l. INTRODUCTION 
The experiments reported in the foregoing indicated that the negative influence 
on the endocrine function of the pancreas after ligation of the pancreatic duct 
did not lead to diabetes mellitus and that this function improved in the course 
of time. These findings led us to apply allotransplantation of the pancreas with 
ligated ducts, which offers several advantages compared with techniques in 
which the ducts are not ligated in order to maintain the exocrine function of 
the pancreas. These advantages, already discussed in Chapter I, are: 
I. The duodenum does not have to be transplanted with the pancreas. 
2. Intestinal anastomoses or even pancreas fistulas are not required. 
3. An anastamosis with the ureter is avoided, and thus the loss of a kidney. 
4. Transplantation of the pancreas with ligated duct is a much simpler oper-
ation. 
Our investigation of the possibilities for combination of the technique of 
pancreas transplantation with a study on the influence of tissue typing for the 
DL-A system enabled us to approach the following problems: 
a. The influence and value of tissue typing in pancreas allotransplantation. 
b. Prolonged survival of some transplants without the administration of 
immunosuppressive drugs, if achieved, would give a clearer picture of the 
endocrine function of the pancreas, since the influence of such drugs would be 
excluded. 
c. The presence of known tissue incompatibility between donor and recipient 
would make it possible to evaluate the effect of various immunosuppressive 
drugs on allotransplantations. 
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For such studies, the endocrine pancreas function of the recipient should be 
abolished before the transplantation. The best way to achieve this seemed to 
us to be the performance of a total pancreatectomy in the recipient some time 
before the transplantation. Conservative depression of the endocrine function, 
for instance with alloxan, was not adopted, because the associated mortality is 
reported to be appreciable and in many cases stable diabetic conditions are 
not obtained (116). 
A number of findings from the preceding experiments were applied to these 
transplantation experiments. Since it had been found (page 35) that function-
ing exocrine pancreatic tissue could still be present after dissection of the 
pancreas from the duodenum, a number of pancreas function tests had to be 
performed after total pancreatectomy to demonstrate the abolition of both the 
exocrine and endocrine functions. Furthermore, the pancreatitis which invari-
ably accompanied duct ligation (page 38) led to a rise in the hematocrit value 
with sludging of erythrocytes, increasing the risk of intravascular coagulation. 
This made it advisable to supply fluids abundantly after pancreas transplanta-
tions; on the basis of GooDHEAD's (43) findings, part of this fluid should consist 
of Rheomacrodex® (dextran 40,000 Mw). Lastly, in connection with the auto-
transplantations (page 45) it was found that hypoglycemia could develop after 
the operation, and we therefore administered glucose intravenously in the post-
operative period. 
2. MATERIAL AND METHODS 
This series of experiments was done exclusively in beagles. The donor-recipient 
pairs were formed on the basis of a prospective serological selection according 
to the DL-A system, as described in Chapter TI. The following groups were 
formed: 
Group 3a; Unrelated non-identical beagle pairs 
Group 3b: Related pairs differing by 2 haplotypes 
Group 3c: Related pairs differing by 0 haplotypes 
Group 3d: Related pairs differing by I haplotype and treated with azathio-
prine and prednisone 
Group 3e: Related pairs differing by I haplotype treated with ALS 
2.1. Pancreatectomy in the recipient 
In 77 beagles, total pancreatectomy was performed according to MARKOWITZ 
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et al. (102). During the operation the animals received 0.9% saline and 10 rnl 
Rheomacrodex 10% per kg body weight, and during the 24 hours after the 
operation !litre 0.9% saline and 300 milO% glucose solution with 16 U insulin 
(Organon) and I g KCI per 500 cc parenterally. On the second post-operative 
day 500 ml 0.9% saline was given once, water ad lib, and, at the beginning of 
the day, 4 U insulin subcutaneously. On the next day the animal was allowed 
to eat ad lib and pancreatic enzymes were given orally. The insulin dosage was 
based on the blood sugar levels. 
2.2. Preparation of pancreatectomized dogs for pancreas allotransplantation 
In the first week after total pancreatectomy, an intravenous GTT was per-
formed and the insulin peak value determined. In the second post-operative 
week the supplementary enzymes were withheld for 5 days, after which the 
feces were investigated for the presence of trypsin and alpha-chymotrypsin. In 
the third week the clinical condition of the dog was evaluated on the basis of 
the body weight, general condition, and liver function. After the third week the 
dog was considered for a transplant on the basis of the following criteria: a) a 
K value of 0 for the GTT; b) no insulin demonstrable in the serum after glucose 
loading; c) proteolytic enzyme activity in the feces less than I U; d) metabolic 
equilibrium, i.e., the dog had to have a good appetite, not show marked loss 
of weight, and be clinically healthy. 
2.3. Preparation of the donor and donor-pancreatectomy 
The same endocrine and exocrine function tests were done in the donor as in 
the recipient. A dog was considered as donor if the function test results were 
normal and no anomalies were revealed by the clinical, chemical, and hemat-
ological routine investigations. 
Under aseptic conditions and endotracheal anesthesia (page 25), the oper-
ation was performed via a long median abdominal incision. The spleen was 
removed and the tail of the pancreas mobilized. The mesenteric vessels were 
ligated distally from their origin from the inferior pancreaticoduodenal artery 
and vein, after which the gut below the duodenum was excised. The aorta was 
then dissected over a distance of about 6 em proximally and distally from the 
origin of the celiac and mesenteric arteries (Fig. 11). Next, the choledochus 
duct was cut, the portal vein dissected, and all branches of the corrmon hepatic 
artery were ligated at the hepatic porta. This left only the gastroduodenal 
artery, whose branch, the right gastroepiploic artery, was ligated, so that blood 
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Fig. I I. Schematic representation of the arterial supply to a pancreas allotransplant. 
reached the pancreas via the superior pancreaticoduodenal artery. The pancreas 
was then dissected from the duodenum, and both pancreatic ducts were isolated, 
cut, and tied off, leaving the organ connected only with the arterial circulation, 
via the celiac and mesenteric arteries, and with the venous circulation via the 
portal vein. 
The donor was then given 3 mg heparin per kg body weight, and 3 minutes 
later the ischemic time was started by clamping of the aorta. The portal vein 
was severed in the hilus of the liver and the aorta segment isolated and cannul-
ated, after which the pancreas was flushed with about 200 ml physiological 
saline containing 25 mg heparin 2% and 50 ml procaine HCI 2% per 500 ml, 
and held at 4'C. (See Plate 7.) 
During the operation the donor received 0.9% saline, Rheomacrodex 10% 
in glucose 5% (about 10 ml per kg body weight), and 25,000 KIU Trasylol. 
After removal of the pancreas, the donor was killed by the adminictration of 
an overdose of Pentothal®. 
2.4. Implantation 
Before the recipient was anesthetized, the hemoglobin, blood sugar, and serum 
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potassium levels were determined. During the beginning of the anesthesia, 
glucose 5% and 8 U insulin were administered by infusion, if necessary with 
the addition of potassium. As an extra measure, a catheter was introduced into 
the carotid artery on the right side to permit continuous recording of the arterial 
blood pressure as well as blood sampling for pH and p02 determinations. ECG 
registration was also continuous. If necessary, acidosis was corrected with 
NaHC03 5%. The basic infusion consisted of a 5% glucose solution, to which 
insulin and KCI were added when required. Via a venous cannula, Rheoma-
crodex 10% was given in a 0.9% saline solution in a dose of 10 ml per kg body 
weight as well as plasma and, if necessary, blood. Just before revascularization, 
50,000 KIU Trasylol was administered. All this was supplied via two infusions 
systems. 
After the abdomen had been opened with a median incision, all of the organs 
were inspected before the aorta and caval vein below the renal vessels were 
dissected. Meanwhile, on another operating table, the donor pancreatectomy 
had been completed. For the transplantation, a side-to-side venous anastomosis 
- · --aorta 
v. cava 
Fig. 12. Drawing showing the vessel-bearing patch implanted in the aorta below the recipient's 
renal arteries. 
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was made with 5 x 0 silk between the portal vein of the transplant and the 
inferior caval vein of the recipient, and after that the flushing of the pancreas 
with cold saline was terminated. A Carrel patch cut around the origin of the 
celiac and superior mesenteric arteries (Plate 8) was sutured with 5 x 0 silk 
to the recipient's aorta (Fig. 12). No further fixation of the pancreas was per-
formed. After the anastomoses and the pancreas had been checked for leakage 
of blood, the abdomen was closed in two layers with tied silk sutures. 
2.5. Post-operative management 
In connection with the problem of pancreatitis, an essential part of the post-
operative management was the supply of abundant fluid in the form of such 
colloidal liquids as plasma and Rheomacrodex. A 5% glucose solution was 
given to compensate for the post-operative hypoglycemia. The infusion scheme 
was as follows: 
Amounts and types offluid given per /0 kg body weight post-operatively 
4th hour 100 ml Rheomacrodex 10% in glucose 5% + I g KCI/500 ml 
100 ml glucose 5% + I g KCI/500 ml 
100-150 ml plasma 
12th hour 100 ml Rheomacrodex 10% in glucose 5% , I g KCI/500 ml 
100 ml glucose 5% + I g KCI 
I 00 ml plasma 
20th hour 100 ml Rheomacrodex 10% in glucose 5% + I g KC[/500 ml 
100 glucose 5% + I g KCI 
75 ml plasma 
28th hour 75 ml Rheomacrodex 10% in glucose 5% + I g KCI/500 ml 
75 ml glucose 5% + I g KCI/500 ml 
In the following phase, 75 ml Rheomacrodex 10% in glucose 5% was given 
parenterally twice daily, with gradual reduction of the amount until on the 
5th post-operative day 50 ml was given once. In some cases it was necessary to 
diverge from this scheme: for instance, when the hemoglobin level became too 
low, plasma was replaced by blood. During the first 5 days, ampicillin (page 25) 
and 50,000 KIU Trasylol were given daily. 
As early as the first post-operative day the dogs were allowed to drink ad lib, 
and on the second day solid food was given together with pancreatic enzymes. 
No additional insulin was given. 
Whenever possible, a GTT was performed and the insulin peak value, liver 
function, and Ca, Mg, and amylase levels were determined once during the first 
5 days after the operation. When the animal's condition did not permit this, only 
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the essential determinations were made, e.g. the hemoglobin, blood sugar, and 
serum potassium levels. The amount of fluid taken orally was recorded. The 
body weight was recorded once a week except in dogs with poor appetite, which 
were weighed every other day. Food was given ad lib. Throughout the post-
operative period, up to rejection, the following determinations were performed. 
The serum glucose level was measured daily in the first post-operative week 
and thereafter 3 times a week, the blood being sampled at arbitrary times, thus 
generally not when the stomach was empty. An intravenous OTT and an insulin 
determination were done weekly, and more frequently when signs of rejection 
were found. Hemoglobin and serum amylase were determined daily during the 
first 5 post-operative days. Liver function was checked once a week. In dogs 
treated with immunosuppressive drugs the blood picture and the number of 
thrombocytes present were checked twice weekly. 
2.6. Criteria for rejection 
Under rejection of an organ transplant we understand the progressive deterior-
ation of organ function due to destruction of the organ by the host. As pointed 
out in Chapter f, in pancreas transplantations other factors can be responsible 
for the loss of the endocrine function, and we therefore applied the following 
criteria for the diagnosis rejection of the pancreas transplant: 
a. Total loss of the endocrine function of the pancreas as demonstrated by: 
I. K value of the GTT approaching nil, and 
2. IPV of less than 20 [LU/ml after glucose loading. 
If signs of diabetes mellitus appeared (e.g. polydisia, high blood sugar values) 
an intravenous GTT was performed and the IPV determined. 
b. The presence of the histological signs characteristic for rejection known 
from the literature (22,94, 113, 153). 
Some of the animals were not in very good condition during this period, so that 
it was not always possible to collect the amount of blood required for a good 
GTT and IPV determination at the usual time. In these cases, two arbitrary 
blood sugar determinations on day X (day X being the day on which an elevated 
blood sugar level was first found) and the fasting blood sugar level on day 
X+ I were considered to suffice. All 3 of these values had to lie higher than 
200 mg %. The day on which function disappeared was then called day X -I. 
As soon as loss of function was observed, the dog was killed. 
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2.7. The immunosuppressive drugs 
In the last 2 experimental groups, 3d and 3e, immunosuppressive drugs were 
used over a period equalling the mean transplant survival time of group 3c. 
The 3c dogs were identical for the DL-A system and could be expected to have 
the longest survival time. It was not necessary to administer the drugs over a 
longer period, because a large number of dogs with a very long survival time 
was not required. 
Group 3d was given a combination of azathioprine and prednisone, the 
former in the form of azathioprine sodium (Burroughs Wellcome & Co, 
London, United Kingdom) in a daily dose of 4 mg per kg body weight, the 
latter as prednisolonacetate (Di-adreson-f®, Organon) given intramuscularly in 
a daily dose of I mg per kg body weight for the first 2 days, followed by pred-
nisone given orally in the same dose. Administration was started immediately 
after the operation. 
Group 3e received an anti-lymphocyte serum provided by the Radiobiological 
Institute-T.N.O. (Rijswijk, The Netherlands). This horse anti-dog anti-lympho-
cyte serum (batch nr. P.M.D. 3-SB) was produced according to GRAY et al. (47). 
A mixture of 10" thymus cells and lymph node cells in Freund's adjuvant was 
injected subcutaneously, and this was repeated 3 weeks later. One week after 
that, the first blood sample (A) was taken. Eight weeks later, the same number 
of cells were injected intravenously. One week later, the second blood sample 
was taken to obtain serum B, which was used in the experiments in a dosage 
of 1.5 ml per kg body weight 3 times weekly. Two days before the transplan-
tation, a double dose was given once, and the following single dose was given 
on the day of the operation. 
3. RESULTS 
3.1. Total pancreatectomy 
All 77 dogs survived the first 48 post-operative hours. After this interval, 6 dogs 
died of hypo- or hyperglycemia, 2 died of peritonitis due to a duodenal per-
foration, and 3 died as the result of intussusception. 
With respect to the first 6 dogs, the following points are relevant. As already 
mentioned, all of the animals received an amount of insulin adjusted to the 
serum glucose level. However, the appetite of the dogs after the operation varied 
widely, and a number died of hypo- or hyperglycemia with blood sugars 
varying from 16 to 720 mg %. 
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With respect to the 2 deaths due to peritonitis, the excision of the recipient's 
pancreas had left the duodenal circulation inadequate because the superior 
pancreaticoduodenal artery was ligated, leading in these cases to perforation 
of the duodenum. As far as the last 2 animals are concerned, it may be noted 
that after both total pancreatomy and transplantation our dogs showed an 
elevated tendency to intussusception (see Table VI, page 64). 
After the total pancreatectomy, most of the dogs did well on the following 
regimen (per 10 kg body weight): Morning: 8 U insulin novo lente (Novo 
Industrie A/S, Copenhagen, Denmark), 4 U insulin (Organon, Oss, The Nether-
lands). Evening: 4 U Insulin (Organon). In addition, food was given ad lib with 
16 tablets Combizym and 8 tablets Cotazym. In a number of cases the solid 
food had to be replaced temporarily by the liquid diet (Wessanen) in which 5 g 
pancreatin and 50 mg lipase was dissolved. All of the dogs lost weight after the 
pancreatectomy, on average 23 per cent of the pre-operative weight in 3 weeks. 
After the transplantation the lost weight was recovered on the same enzyme 
regimen. 
Two of the dogs became severely cachetic and had to be killed. In one the 
post-operative function determination showed that there was still some endo-
crine and exocrine function; this dog was not considered for transplantation. 
Thus, 64 dogs remained available for transplantation. These dogs satisfied 
the already-mentioned criteria: a) K value of intravenous GTT = 0; b) serum 
insulin peak value < 3 fLUfml after glucose loading; c) proteolytic enzymes in 
the feces < I U. 
3.2. General transplantation results 
3.2.1. Surgical mortality 
Four dogs died during the operation or within the first 24 hours, three due 
to an electrocardiographically demonstrated ventricular fibrillation caused by 
hypokalemia and one from severe post-operative hypoglycemia despite the ad-
ministration of more than the standard amount of glucose. 
As a result of these complications, which occurred in the first 12 cases, the 
serum glucose, serum potassium, and serum insulin levels were determined in 
the next 15 transplantations at the following times: a) shortly before the pre-
paratory anesthesia; b) shortly before revasculatization of the transplant; 
c) immediately after revascularization of the transplant; d) at the termination 
of the anesthesia. 
The results are shown in Fig. 13, where the composition of the infusions 
administered during the operation are also given. At the start of anesthesia the 
mean potassium content of the blood was 5.1 mmoljlitre and the glucose con-
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Fig. 13. Average course of the insulin, potassium, and glucose levels in the serum of 15 dogs 
given a pancreas allotransplant. 
tent 330 mg %. There was then no endogenous insulin in the circulation. After 
revascularization the picture changed radically and a good insulin level with 
a mean value of 175 iJ.U/ml developed. This led to a sharp drop in the serum 
potassium and glucose levels despite the administration of both by infusion. 
In addition, most of the dogs proved to be slightly acidotic just before being 
anesthetized. 
On the basis of these findings, pathological changes in the serum potassium 
and glucose levels and/or the pH value of the blood occurring during or im-
mediately after the operation were corrected, after which the surgical mortality 
dropped to nil. 
3.2.2. Post-operative course 
a. Serum glucose level 
The course of the mean serum glucose level is shown in Fig. 14. It is evident 
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Fig. 14. Mean fasting serum glucose levels fOr 20 dogs alter pancreas allotransplantation. 
10 
that despite the administration of glucose the values were lower on the first 
two post-operative days than on the following days. This pattern was the same 
for all of the groups. On the third or fourth post-operative day a OTT was 
done in each dog and the K value calculated; the results will be discussed 
separately under Experimental groups. 
b. Hemoglobin level 
The hemoglobin content of the blood varied only on the first two days after 
the operation. The pancreatitis led to elevated hematocrit values, which in turn 
caused sludging, but this was sometimes camouflaged by post-operative bleed-
ing. This picture was the same for all groups except group 3e, in which a toxic 
side-effect of the administration of ALS led to further depression of the hemo-
globin level. We shall return to this point below. 
c. Serum amylase leFel 
The serum amylase level varied widely in all of the groups. On the third post-
operative day, for instance, the values ranged from 512 U to 32,768 U Wohl-
gemuth. In the individual dogs, however, there was a gradual rise, the highest 
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Fig. 15. Mean serum amylase levels for 20 dogs ajter pancreas allotransplantation. 
values usually occurring on the third post-operative day. After the tenth day, 
elevated values were only seen twice. The course of the mean serum values of 
20 randomly selected dogs representing all of the groups is shown in Fig. 15. 
d. Serum insulin level 
As can be seen from Fig. 14, the serum insulin level was high immediately after 
the operation. On the first post-operative day the serum insulin level determined 
arbitrarily without stimulation still had a mean value of 40 fCU/ml. The insulin 
peak value is, however, much more important for the evaluation of the endo-
crine pancreas function, and will be discussed on the basis of the individual 
dogs under Experimental groups. 
e. Other determinations 
The results of the other determinations mentioned in Chapter II were not 
divergent after transplantation with the exception of a number of hematological 
values in dogs treated with immunosuppressive drugs, which will be discussed 
under the relevant groups. 
f. Deaths shortly after transplantation 
Of the 60 dogs which could be followed after the transplantation, two had 
glucose values varying from 280 to 310 mg % immediately after the operation. 
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TABLE VI 
Endocrine function and cause of death in cases of early mortality after pancreas transplantation. 
Dog nr. Nr. of 
haplo-
Nr. of 
days 
types post-
diff. oper. 
between survival 
littermates 
B 9.227 2 2 
BD 9.178 2 7 
B 0.195 2 2 
BD 0.337 7 
B 1.247 8 
BD 1.219 6 
Endocrine 
function at 
time of death 
normal blood 
sugar values 
K ~ 1.6 
!PV ~ 
240 [J.U/ml 
normal blood 
sugar values 
normal blood 
sugar values 
K ~ 3.5 
!PV ~ 
130 p.U/ml 
Cause of 
death 
unknown 
intussus-
ception 
unknown 
intussus-
ception 
intussus-
ception 
K = 3.5 unknown 
IPV ~ 71 ~U/ml 
Post-mortem findings 
---··--~··· 
Cause of death: splenic he-
morrhage. Pancreas: some 
interstitial edema and mild 
superficial pancreatitis; no 
signs of rejection. 
Cause of death: intussus-
ception. Pancreas: no pan-
creatitis; fibroid degenera-
tion of acinar tissue; signs of 
onset of rejection. 
Cause of death: unknown. 
Venous anastomosis shows 
fresh thrombus. Pancreas: 
normal appearance except 
for some edema in intersti-
tial tissue and very slight 
cellular infiltration. 
Cause of death: 75 em gut 
necrotic. Pancreas: edema 
with loss of granulation; 
slight indications of pancre-
atitis; atrophic acini; no 
signs of rejection. 
Cause of death: intussuscep-
tion. Anastomoses patent. 
Pancreas: signs of pancrea-
titis; infarctions; almost no 
cellular infiltration; exten-
sive arteritis with intimal 
swelling and fibroid ne-
crosis. 
Cause of death: hemorrhage 
arterial anastomosis. Ve-
nous anastomosis patent. 
Pancreas: mild edema; mild 
pancreatitis; no signs of re-
jection. Pancreas picture 
normal. 
--···-~· 
(Continued on p. 65) 
Dog or. Nr. of 
haplo-
Nr. of 
days 
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TABLE VI. Continued 
Endocrine 
function at 
Cause of 
death 
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Post-mortem findings 
types post- time of death 
BD 0.301 
diff. oper. 
between survival 
Jittermates 
0 
BD 9.157 0 5 
B 0.177 0 7 
Non-littermates 
B 0.260 incom- 7 
patible 
BD 0.193 incom- 5 
patible 
normal blood 
sugar values 
normal blood 
sugar values 
K ~ 2.1 
IPV ~ 
190 ~U/ml 
I day normal 
blood sugar 
values, 
then high 
K ~ 2.0 
blood sugar 
values 
normal 
relaparo-
tomy for 
volvulus 
followed by 
arterial 
Cause of death: art. throm-
bosis after relaparotomy. 
Status after resection large 
intestine. Pancreas: exten-
sive arterial thrombosis and 
thrombosis pancreatitis. No signs of re-
transplant jection. 
hypoxemia Cause of death: hypoxemia. 
bleeding 
from venous 
anast. 
Pancreas: pancreatitis and 
venous thrombosis. No 
signs of rejection. 
Cause of death: hemorrhage. 
Pancreas: fibrotic replace-
ment of acinar tissue; ex-
tensive mononuclear cell in-
filtration; intimal swelling. 
killed Pancreas: arterial throm-
because basis at sutures; complete 
trans. failed necrosis. 
to function 
unknown Cause of death: hemor-
rhagic pancreatitis. Anasto-
moses patent. Pancreas: 
hemorrhagic necrosis with 
infarction; perivascular cel-
lular infiltration. 
These dogs were killed on the second post-operative day, and both were found 
to have thromboses in the venous vascular anastomosis. These were the only 
animals in which the transplant had not functioned at all. Of the other 58 dogs, 
11 died in the first week after the first few post-operative days. Some data on 
these 11 dogs, including the endocrine pancreas function and cause of death, 
are shown in Table VI, from which it can be seen that thrombosis in an anas-
tomosis was only found once after the first 24 hours and that intestinal strangu-
lation was the cause of death in four cases. Thus, 47 dogs with a functioning 
transplant were available for further study. 
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3.3. Experimental groups 
The 47 surviving dogs were distributed over the groups as follows: 
Group 3a: unrelated, not identical 9 
Group 3b: related, not identical (differing by 2 haplotypes) 9 
Group 3c: related, identical (differing by 0 haplotypes) 13 
Group 3d: related, not identical (differing by 1 haplotype, treated 
with azathioprine and prednisone) 9 
Group 3e: related, not identical (differing by I haplotype, treated 
with ALS) 7 
The results will be discussed for each group separately and the data shown in 
2 Tables for each group. The first of these Tables gives the highest serum 
glucose values for the first 2 post-operative days, when these values were rela-
tively too low. The hemoglobin values of these 2 dogs are also shown, because 
this is the period in which the level fluctuated. The endocrine function is reflected 
in the K values and the IPV; the highest values registered in the first month 
are given but not those of the first post-operative week for the dogs with a 
longer survival time. The IPV invariably corresponded with the K value (for 
the course of the endocrine function in these five groups, see § 4). The clinical 
cause of death is also indicated. The second Table gives the duration of trans-
plant function, the criteria for zero or almost zero function, the histological 
data on the transplant, and the final cause of functional failure. To permit 
comparison of the histological data of the various groups, the following grading 
was applied: 
Pancreatitis: 
Very mild (only interstitial edema) + 
Moderate (edema and local parenchymal necrosi~ due to auto-
digestion) + + 
Severe (edema and local parenchymal necrosis with hemorrhages) + + + 
Rejection: 
Distinction of an interstitial component with infiltration of mono-
nuclear cells (lymphocytes, lymphoblasts, plasma cells) in tissue 
and perivascularly, and a vascular component with swelling of 
the intima, fibrinoid necrosis of the media, and thrombus forma-
tion in the smaller blood vessels. 
a. Interstitial rejection phenomena 
Mild (local cellular infiltration limited to the superficial area 
of the organ) + 
Moderate (general cellular infiltration but mainly on and 
near the organ surface) -1- + 
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Sovere (cellular infiltration throughout, particularly between 
and around the blood vessels) + + + 
b. Vascular rejection phenomena 
Mild (only swelling of the intima) + 
Moderate (intimal swelling with fibrinoid necrosis in the 
media) ++ 
Severe (initial swelling, fibrinoid necrosis, thrombus for-
mation) +++ 
3.3.1. Group 3a: unrelated, non-identical beagles 
The data for this group are shown in Tables VII and VIII. In general, the K 
values lie under and the IPV above the normal level. Dogs BD !.222 and B 171 
TABLE VII 
Post-operative values and endocrine function in group Ja. 
Dog nr. Blood sugar values Hemoglobin content Highest Insulin Cause of 
(mg%) (g%) K value peak death 
%/min. values 
(~U/ml) 
----"··-----~-~--------- ··-~----- ------- ---~---------- ·------
1st day 2nd day 1st day 2nd day 
BD 1.195 56 68 13.4 10.9 3.4 163 Killed 
BD 1.271 74 83 13.6 13.6 2.2 135 Killed 
B 0.335 77 67 10.2 12.8 2.4 240 Unknown 
B 1.183 79 59 15.7 13.1 2.4 240 Killed 
BD 0.314 67 6! 14.6 13.6 3.3 133 Killed 
BD 578 65 56 13.9 14.4 2.0 210 Killed 
BD 1.222 48 68 13.1 13.0 3.5 57 Killed 
B 171 56 81 18.2 15.5 3.0 170 Killed 
B 184 25 25 II. 7 11.6 4.1 Killed 
----------------------------- ·------~--------------
had fasting blood sugar values of 90 mg % and 85 mg %, respectively, at a 
time when the K value had reached zero and the IPV was very low. In this 
group rejection was the cause of the loss of the endocrine pancreas function. 
As a rule, this was accompanied by a mild pancreatitis. The mean transplant 
survival time was 9.6 days. 
3.3.2. Group 3b: related, non-identical beagles differing by 2 haplotypes 
The data on these dogs are shown in Tables IX and X. In dog nr. BD 0.284 
the values on the sixth post-operative day were K ~ 0 and IPV ~ 0, indicating 
that the transplant had been rejected. Insulin could not be determined in nr. 
BD 382 because antibodies against the administered insulin were demonstrated 
in the period without the pancreas (41 days). The K value ofB 0.217 could not 
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Dog nr. 
BD Ll95 
BD L271 
B 0.335 
B Ll83 
BD 578 
BD 0314 
BD L222 
B 171 
B 184 
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TABLE VI!l 
Transplant survival and post-mortem findings in group Ja. 
Nr. days Clinical indications for 
transplant abolition of function 
function 
II K ~o 
Ins.: not demonstrable 
8 High blood sugar values* 
10 Normal blood sugar values 
15 K~O 
Ins.: 2 [LU/ml 
8 K ~ 0 
Ins.: 4 y.U/ml 
II High blood sugar values* 
8 K ~o 
Ins.: 2 p.U/ml 
8 K~O 
Ins.: 10 1.1.U/ml 
8 K "~ 0 
Ins.: 6 [J.U/ml 
···--------------··--
--~-------
Post-mortem findings Final diagnosis 
(with grades)** 
-------
Pancreatitis + + 
Interstitial T + + 
Vascular -
Anastomoses intact 
Pancreatitis + 
Interstitial + + 
Vascular++ 
Anastomoses intact 
Pancreatitis + + 
Interstitial , + 
Vascular + 
Anastomoses intact 
Pancreas: cysts 
Pancreatitis + 
Interstitial + + + 
Vascular+ 
Anastomoses intact 
Early fibrosis of 
acinar tissue 
Pancreatitis -
Interstitial __;__--:-
Vascular + 
Anastomoses intact 
Anastomoses intact 
No histological data 
(technical failure) 
Early fibrosis of 
acinar tissue 
Pancreatitis + 
Interstitial + + + 
Vascular + 
Anastomoses intact 
Pancreatitis -
Interstitial .. ..L 
Vascular++ 
Anastomoses intact 
Pancreatitis + 
Interstitial + + 
Vascular++ 
Anastomoses intact 
Rejection with 
pancreatitis 
Rejection with 
pancreatitis 
Rejection with 
pancreatitis 
Rejection with 
pancreatitis 
Rejection 
Rejection 
Rejection 
Rejection 
Rejection with 
pancreatitis 
* Blood samples too small to permit calculation of K value. 
** Rejection phenomena shown as interstitial and vascular components. 
Grading: =none 
+ =mild 
++ =moderate 
+++ = severe 
Dog nr. 
BD 0.283 
BD 0.190 
BD 0.284 
B 0.248 
B 0.284 
BD 0.213 
BD 0.237 
BD 0.206 
B 0.217 
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TABLE IX 
Post~operative values and endocrine function in group 3h. 
~~-····--
Blood sugar values 
(mg %) 
I st day 2nd day 
113 101 
76 
54 
85 
61 
79 
74 
59 
65 
81 
20 
79 
87 
88 
97 
56 
65 
Hemoglobin content Highest Insulin 
(g %) K value peak 
(%min) value 
(p.U/ml) 
.~---
··----
1st day 2nd day 
11.3 13.4 2.7 anti~ 
bodies 
12.9 12.9 2.6 49 
21.0 19.4 
11.6 14.2 2.2 92 
17.7 13.3 1.8 57 
16.1 12.6 3.9 92 
11.8 12.8 2.3 
16.9 15.1 3.0 
10.6 12.8 38 
. ~~---------~--
Cause of death 
killed 
hyperglycemia 
hyperglycemia 
killed 
killed 
killed 
killed 
hyperglycemia 
hyperglycemia 
be calculated because the GTT showed unexplained fluctuations, but the IPV 
could be determined. 
In this group, too, the main causes of the loss of the endrocrine pancreas 
function were rejection and pancreatitis. The mean transplant survival time 
was 10.5 days. 
3.3.3. Group 3c: related, identical beagles differing by 0 haplotypes 
For this group the data are shown in Tables XI and XII. Here, the IPV could 
not be determined in 2 dogs (B 0.340 and BD 9.141) after the transplantation, 
because 27 and 47 days, respectively, after the administration of insulin was 
started antibodies were found to be present. At the end of the study, dogs 
BD 622 and BD 617 were still alive, so no autopsy data are available. 
Of the 13 dogs in this group, 7 were killed because the organ was rejected. 
The two which survived the first year have a good endocrine function. If, how-
ever, the survival time of the transplant in these two cases is taken equal to 
that of BD 9.161, which lived 69 days, the mean survival time of the transplants 
in this group amounts to 42.9 days. 
3.3.4. Group 3d: related, non-identical beagles differing by I haplotype and 
treated with azathioprine and prednisone 
Tables XI!I and XIV show the data concerning these dogs. The immunosup-
pressive drugs were given for 42 days. This duration of treatment was chosen 
as being virtually equal to that of the mean transplant survival time of group 3c. 
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TABLE X 
Transplant survival and post-mortem findings in group 3b. 
Dognr. Nr. days Clinical indications for 
transplant abolition of function 
function 
Post-mortem findings Final diagnosis 
(with grades)** 
BD 0.283 29 
BD 0.190 10 
BD 0.284 5 
B 0.248 12 
Polydipsia 
High blood sugar values 
K ~ 0 
K~O 
Ins. = 0 
K ~ 0 
High blood sugar values 
High blood sugar values 
K ~o 
Ins. = 0 
Pancreatitis + 
Interstitial + 
Vascular ++ 
Anastomoses intact 
Pancreatitis + 
Interstitial + + + 
Vascular -.-!....-;-
No acinar tissue 
Extensive fibrosis 
with autolytic cysts 
Anastomoses intact 
Pancreatitis +- -!-
Interstitial + --
Vascular ··f-
Anastomoses intact 
Pancreatitis + 
Interstitial ..c..++ 
Vascular --'-
Re_iection with 
pancreatitis 
Acute rejection, 
enzymic auto-
digestion 
Rejection with 
pancreatitis 
Rejection with 
pancreatitis, 
local throm-
Anastomoses intact basis 
B 0.284 9 
BD 0.213 6 
BD 0.237 7 
BD0.206 8 
B 0.217 9 
High blood sugar values 
K ~- 0 
Ins. = 4 tLU/ml 
High blood sugar values 
K ~ 0 
Ins. = 0 
High blood sugar values 
K ~o 
High blood sugar values* 
High blood sugar values 
K ~ 0 
Ins. = 0 
Pancreatitis + + 
Interstitial + 
Vascular + 
Anastomoses intact 
Pancreatitis + + 
Interstitial + + 
Vascular -
Thrombotic anast. 
Pancreatitis + 
Interstitial + + 
Vascular -
Severe pneumonia 
with abscess 
formation 
Anastomoses intact 
Pancreatitis + 
Interstitial + + 
Vascular -!-
Anastomoses intact 
Pancreatitis -
Interstitial ..:,_ 
Vascular++ 
* Blood samples too small to permit calculation of K values. 
** Rejection phenomena shown as interstitial and vascular components. 
Grading: = none 
+=mild 
+ + = moderate 
+++=severe 
Rejection with 
pancreatitis 
Rejection, 
pancreatitis, 
thrombosis 
Rejection with 
pancreatitis 
Rejection with 
pancreatitis 
Rejection with 
pancreatitis 
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TABLE XI 
PostMoperative values and endocrine function in group 3c 
Dog nr. Blood sugar values Hemoglobin content Highest Insulin Cause of death 
(mg %) (g %) K value peak 
(% min) value 
(vU/ml) 
lst day 2nd day 1st day 2nd day 
B 619 67 92 15.4 I 3.6 2.0 62 killed 
BD 0.294 59 94 18.2 15.8 3.8 killed 
BD9.161 90 92 14.3 13.1 3.2 123 killed 
BD 0.164 74 72 16.8 15.2 4.6 240 killed 
B 0.262 65 74 18.5 17.1 2.6 160 killed 
B 578 65 101 14.9 11.8 3.4 82 unknown 
B 556 65 103 18.2 10.1 1.8 hemorrhage 
BD 622 86 70 12.6 8.8 4.6 224 still alive 
B 558 97 90 10.9 12.5 3.5 24 killed 
B 0.340 86 65 12.6 13.7 3.8 antibodies killed 
BD 617 88 94 14.2 13.8 4.0 240 still alive 
BD 9.276 65 65 18.4 16.8 1.8 80 unknown 
BD 9.141 34 52 15.6 17.6 2.8 antibodies pneumonia 
"·~--------- ------~---· 
N r. B 649 is a good example of a dog in such poor condition that sufficient 
blood for the GTT and IPV determination could not be taken at the scheduled 
times. No hematological anomalies were found. 
Of the 9 dogs in this group, 8 were killed because the endocrine function 
disappeared due to rejection of the transplant. The mean survival time of the 
transplants was 34.2 days. 
3.3.5. Group 3e: related, non-identical beagles differing by I haplotype and 
treated with ALS 
The data for this group are shown in Tables XV and XVI. The very high IPV 
are again striking. Dog nr. BD 0.201 is the only one in this group to die with 
a functioning pancreas; the cause of death proved to be a defective arterial 
anastomosis. Of these 7 dogs, 5 were killed because of rejection of the trans-
plant. Of the two remaining dogs, one bled to death and one is still alive even 
though ALS was withdrawn on the 42nd post-operative day. We have equated 
the survival time of this dog with that of the dog with the longest transplant 
survival time ending in rejection at 90 days. On this basis, the mean transplant 
survival time for this group is 57.0 days. 
The unfavorable effect of ALS on the hemoglobin level and the morpholo-
gical blood picture was unmistakable. Fig. 16 shows the course of the mean of 
the hemoglobin level in this group up to the 7th post-operative week, the first 
value indicated being the pre-operative level and the second the result of the 
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Dog nr. 
B 619 
BD0.294 
BD 9.161 
BD 0.164 
B 0.262 
B 578 
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TABLE XII 
Transplant survival and post-mortem findings in group 3c. 
Nr. days 
trans pl. 
function 
22 
12 
69 
59 
39 
12 
Clinical indications 
for abolition of 
function 
K ~ 0 
IPV ~ 0 
K ~ 0 
High blood sugar 
values 
Polydipsia 
K~O 
1PV ~ 0 
(Persisting function) 
K ~o 
IPV ~ 24 
Post-mortem findings 
(with grades)* 
Pancreatitis -
Interstitial + 
Vascular + 
Extensive fibrotic areas 
with intact islets 
Anastomoses intact 
Pancreatitis -
Interstitial + 
Vascular++ 
Moderate fibrosis, 
islets intact 
Anastomoses intact 
Pancreatitis -
Interstitial + + 
Vascular + 
Total fibrotic degen. 
acinar tissue with 
of 
recognizable islet cells 
Anastomoses intact 
(Plates 12 & 15) 
Pancreatitis -
Interstitial _c__ 
Vascular+ 
Total fibrotic degen. of 
acinar tissue with 
intact islet cells 
Anastomoses intact 
(Plates 13 & 14) 
Pancreatitis -
Interstitial + + 
Vascular + 
Total fibrotic degen. 
of acinar tissue, islets 
intact 
Anastomoses intact 
Final diagnosis 
Rejection 
Rejection 
Rejection 
Killed because of 
multiple abscesses 
after relaparotomy 
for severe ileus 
(resection of entire 
small intestine) 
Rejection 
(Persisting function) Pancreatitis - Rejection 
Interstitial + + + 
Vascular++ 
Fibrosis, intact islets in 
surviving acinar tissue 
Anastomoses intact 
·-··-··-~-·--···--···--···--···--~ ·---·· 
(Continued on p. 73) 
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TABLE XU. Continued. 
---~ ~~---~~--- --- ~--- ~~~~~----
Dog or. 
B 556 
BD 622 
B 558 
Nr. days Clinical indications Post-mortem findings 
(with grades)* transpl. for abolition of 
function function 
8 
365 
36 
(Persisting function) Pancreatitis -
Interstitial -:-
Vascular -
Early fibrosis 
(Persisting function) 
K ~o 
!PY ~ 0 
Arterial anas. ruptured 
Pancreatis -
Interstitial + + 
Vascular -
Total fibrotic degen. of 
acinar tissue, islets intact 
Anastomoses intact 
Final diagnosis 
Bleeding from 
arterial anastomosis 
Still alive 
Rejection 
B 0.340 42 K~O 
antibodies 
Pancreatitis - Rejection 
Interstitial +..., 
Vascular++ 
Total fibrotic degen. of 
acinar tissue, islets 
intact 
Anastomoses intact 
BD 617 365 (Persisting function) 
BD 9.276 II 
BD9.141 35 
(Persisting function) Pancreatitis -
Interstitial --i-
Vascular --i-
Extensive fibrosis of 
acinar tissue showing 
islets 
Signs of pulm. embolism 
and pneum. foci 
(Persisting function) Pancreatitis -
Interstitial -
Vascular -
Total fibrotic degen. of 
acinar tissue, islets 
recognizable 
Pulmonary congestion, 
pneum. foci 
* Rejection phenomena shown as interstitial and vascular components. 
Grading: = none 
+=mild 
+- = moderate 
+....!...- =severe 
Still alive 
Pulmonary embolis 
and pneumonia 
Pneumonia 
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TABLE Xlll 
Post-operative values and endocrine function in group Jd 
----------
Dog nr. Blood sugar values Hemoglobin content Highest 
K value 
(%min) 
Insulin Cause of death 
(mg %) (g %) peak value 
(~U/m1) 
1st day 2nd day 1st day 2nd day 
BD 653 40 79 16.8 13.4 2.6 135 
B 2.152 40 79 13.4 15.5 3.5 120 
B 2.206 70 97 15.8 13.9 4.1 179 
BD 2.219 70 84 12.6 12.3 4.1 107 
B 2.228 56 72 17.4 14.4 2.6 48 
BD 2.204 65 65 13.1 12.3 2.8 90 
B 2.213 90 100 11.0 11.5 4.3 76 
B 649 54 67 17.4 14.9 
B l.JSO 97 86 13.3 13.0 2.6 87 
-----
-----·-" 
TABLE XIV 
Transplant survival and histological findings in group 3d 
Dog nr. 
BD 653 
Nr. days Indications for 
transpl. abolition of 
function function 
--------
8 K ~o 
Ins. not demon-
strable 
B 2.152 62 K ~ 0 
Ins.: 2 tJ.U/ml 
Post-mortem findings 
(with grades)** 
Pancreatitis -;-
Interstitial -
Vascular++ 
Extensive fibrosis 
Thromb. art. anas. 
Pancreatitis -
Interstitial -·-
Vascular + --1- -;-
Extensive necrosis due to vas-
culitis and thrombus formation 
Anastomoses intact 
killed 
killed 
killed 
killed 
killed 
killed 
killed 
k111ed 
killed 
Final 
diagnosis 
Arterial 
anastomoses 
thrombotic 
Rejection 
B 2.206 73 High blood 
sugar values* 
Pancreatitis - Rejection 
BD 2.219 26 
B 2.228 7 
K ~o 
Ins.: 4 iJ.U/ml 
Interstitial + 
Vascular + -1- + 
Total fibr. degen. of acinar tissue 
Anastomoses intact 
Pancreatitis -
Interstitial -
Vascular+++ 
Total fibr. degen. of acinar 
tissue; islet tissue here and there 
Anastomoses intact 
K = 0 Pancreatitis -
Ins.: 10 [J.U/ml Interstitial + 
Vascular++ 
Total fibr. degen. of acinar 
tissue, no islets 
Anastomoses intact 
Rejection 
Rejection 
-------·-· 
(Continued on p. 75) 
Dog or. Nr. days 
transpl. 
function 
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TABLE XIV. Continued 
Indications for 
abolition of 
function 
Post-mortem findings 
(with grades)** 
Final 
diagnosis 
75 
--- --··--·· 
BD 2.204 27 K ~ 0 Pancreatitis --
Ins.: 16 [1-U/ml Interstitial+ 
B 2.213 31 K ~ 0 
Vascular + + + 
Moderate fibrosis, some recog-
nizable acinar tissue and islets 
Anastomoses intact 
Pancreatitis -
Ins.: 12 fLU/ml Interstitial+ 
B 649 21 
B 1.180 27 
High blood 
sugar values* 
K ce 0 
Ins.: 2 (LU/ml 
Vascular , + -r· 
Total fibr. acinar tissue, some 
recogn. islets 
Anastomoses intact 
Pancreatitis -
Interstitial + 
Vascular + + + 
Total fibr. acinar tissue. some 
islets present 
Anastomoses intact 
Pancreatitis -
Interstitial + 
Vascular+++ 
Total fibr. acinar tissue, islets 
easily recogniable 
Anastomoses intact (Plates 18-21) 
* Blood samples too small to permit calculation of K value. 
** Rejection phenomena shown as interstitial and vascular components. 
Grading: = none 
+=mild 
+ + = moderate 
+ + + =severe 
TABLE XV 
Post-operative values and endocrine functions in group 3e 
---······ ··--- ··--···· 
Rejection 
Rejection 
Rejection 
Rejection 
Dog nr. Blood sugar values Hemoglobin content Highest Insulin Cause of death 
(mg %) (g/~) K value peak value 
(;'lo min) ([.tU/m]) 
----·"' ----··-------
--·----·-
1st day 2nd day 1st day 2nd day 
B 626 92 81 9.1 11.8 3.8 240 killed 
BD 619 74 70 14.2 14.6 3.9 16 killed 
B 0.211 54 76 13.6 13.3 3.0 240 hyperglycemia 
B 614 67 56 13.9 11.8 2.6 46 killed 
B 591 67 83 9.1 9.3 2.3 205 still alive 
B 616 29 95 11.8 11.7 3.8 240 killed 
BD 0.201 61 61 12.6 16.0 3.7 100 bleeding from 
anastomosis 
---·····.-~---·· ··---··· 
----··---· 
76 
Dog nr. 
B 626 
BD 619 
B 0.211 
B 614 
B 591 
B 616 
BD0.201 
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TABLE XVI 
Transplant survival and post-mortem findings in group 3e 
Nr. days Indications for Post-mortem findings 
(with grades)* transpl. abolition of 
function function 
68 K ~o Pancreatitis ~ 
IPV = 12 p .. Ujml Interstitial --
Vascular _L--:-
Total fibr. degen. of acinar 
tissue, easily recognized islets 
Anastomoses intact 
33 K ~ 0 Pancreatitis -~ 
IPY ~ 0 Interstitial + 
Vascular ----:-
Acinar tissue almost entirely 
replaced by connective tissue, 
islet tissue in most areas 
Anastomoses intact 
(Plates 16 & 17) 
90 K~O Pancreatitis -
IPY ~ 0 Interstitial + 
Vascular++ 
Total fibr. degen. of acinar 
tissue, sparse islets 
Anastomoses intact 
35 K ~c 0 Pancreatitis --
IPY ~ 0 Interstitial -
Vascular++ 
Total fibr. degen. of pancreas 
Anastomoses intact 
365 (Persisting Still alive 
function) 
28 K ~0 0 Pancreatiti<; -
Ins.: fi ~J.U/ml Interstitial + 
Vascular++ 
Total fibr. degen. of acinar 
tissue, islets virtually 
indistinguishable 
Anastomoses intact 
14 (Persisting Pancreatitis --
function) Interstitial + 
Vascular + 
Total fibr. degen. of acinar 
tissue, islets clearly recognizable 
Arterial anastomosis partially 
ruptured 
··-----,~,----
* Rejection phenomena shown as interstitial and vascular components. 
Grading: = none 
+=mild 
+ + = moderate 
+ -·· = severe 
Final diagnosis 
Rejection 
Rejection 
Rejection 
Rejection 
Good pancreatic 
function 
Rejection 
Fatal 
hemorrhage 
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hemoglobin in g % 
16 
14 
12 
10 
8 
6 
0 2 3 4 5 6 7 8 
weeks after transplantation 
Fig. 16. Average course of the hemoglobin level in group 3e. 
determination at the end of the first post-operative week. The most pronounced 
drop in the hemoglobin level occurred in the third post-operative week, despite 
blood transfusion. The amount of blood given after the second post-operative 
day is shown in Table XVII. Figs. 17, 18, and 19 give the results of the leukocyte, 
lymphocyte, and thrombocyte counts made at the same time as the hemoglobin 
determinations. 
4. THE ENDOCRINE FUNCTION 
In the dogs with a brief duration of transplant function the GTT and IPV 
determination could only be performed once or twice and there was little point 
in analysing the endocrine pattern. For the dogs with longer transplant function, 
the same picture was found in all groups. The first post-operative K value was 
usually slightly under the normal and the IPV often above the normal level. 
The K value returned to normal during the first 4 weeks; and the IPV dropped 
to a slightly lower level. Both values dropped one or two weeks before rejection. 
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TABLE XVII 
Amount of blood administered to dogs of group Je after the 2nd post-operative day 
Dog nr. 
B 626 
BD 6\9 
B 0.211 
B 614 
B 591 
B 616 
Amount of blood 
(in ml) 
550 
1000 
3200 
2900 
700 
700 
3 leukocytes (x 100 mm ) 
300 
200 
100 
0 2 3 4 5 6 7 
weeks after transplantation 
Fig. 17. Average course oft he leukocyte counts in group Je. 
Fig. 20 shows the course of these values for group 3c, but these means should 
only be considered to give a rough impression because they concern different 
numbers of animals. 
As can be seen from Fig. 20, the mean IPV rose again just before the dogs 
were killed. This elevation was due to a sudden rise of the IPV at a low K value 
in one dog belonging to this group. The course of the IPV in this dog (BD 0.164) 
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lymphocytes per 100 leukocytes 
thrombocyte• (x 1000 per mm 3) 
10 400 
350 
300 
4 250 
2 200 
150 
4 7 
weeks ofter tronsplonlolion 
Fig. 18. Average course ()(the lymphocyte counts in group Je. 
Fig. 19. Average course of the thrombocyte counts in group Je. 
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Fig. 20. Variat;on in the mean K value and insulin peak values a}ter pancreas al/otransp!a!lfation 
in group Jc. 
is shown in Fig. 21. Seen retrospectively, the relevant blood samples might 
have been collected just before rejection occurred; since the IPV was only 
determined once a week, it was pure chance that the determination was made 
at this time. 
The occurrence of high insulin levels just prior to rejection was first discussed 
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by GRENIER et a/. (51), who explained it as due to the measurement not of 
insulin but of proinsulin liberated by cell damage associated with rejection. 
This is supported by the absence of a drop in the serum glucose level in the 
presence of high IPV. 
0 K value insulin 
------· insulin peak value 
peak value 
K value (%/min) I )J U /mil 
5 __ , 250 
' ' 0 0 ' 
' 
' ' ' ' ' 4 
,... 
' ' 200 
' 
' 
' ' 
' 
' ' 
' ' 
' 
' 0 3 ' • 150 ' " 
' ' ' ' 
' 
0 
' ' ' 
' 
0 •, ' 0 ' 0 ' 
' ' 
' 
' 
' ' ' ' 2 ' ' 'o' ' ' 100 
' 
' • ' 
' ' ' 
' ' 
' ' ' ' ,. 
50 
0 2 3 4 5 6 7 8 
weeks post -op. 
Fir;. 21. Variation in the K value and insulin peak value in dog. nr. BD 0164 after pancreas 
allotransplantation. 
Because the endocrine function showed the same pattern in all of the cases 
of long transplant survival, we shall limit ourselves to a detailed discussion of 
the group with the longest survival time, as exemplary, and of the dogs with a 
transplant that functioned more than a year. 
4.1. Endocrine function in group 3e 
Fig. 22 shows the course of the K values in this group. The two high values in 
the 8th post-operative week concern the two dogs with the longest survival 
time. In Fig. 23 the course of the !PV and the corresponding K values are given 
for 5 dogs separately. The IPV for the first week is missing for BD 619 and 
B 626 because sampling could not be performed at the right time in the usual 
way. The sixth dog in this group (B 59!) is not included because, for the same 
rea con, there were too few IPV available; this animal is discussed in § 4.2. 
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K value(% min) 
5 
4 
3 
2 
9 10 11 weeks post-op. 
Fig. 22. K values o/6 beagles of.group 3e before and after pancreas allotransplantation. 
Dog. Pre-op. Weeks post-op. 
nr. value 2 3 4 5 6 7 8 9 10 II 
B 591 2.4 2.3 2.0 3.8 3.7 2.6 3.1 3.3 4.6 4.6 2.9 4.6 
BD 619 4.2 3.9 3.3 2.7 2.4 0 
B 626 2.6 3.8 2.4 2.2 1.7 1.6 2.3 1.2 1.3 0 
B 616 3.8 3.2 2.0 3.8 2.3 0 
B 0211 2.6 2.3 3.0 2.6 2.3 3.6 3.0 3.8 2.9 3.3 1.8 0 
B 614 2.5 2.6 1.5 0.3 2.0 0 
4.2. The endocrine function one year after transplantation 
Although no special attempt was made to achieve very long survival times -
all immunosuppressive drugs were withheld starting in the sixth week - there 
were three dogs in which the transplant was not rejected, i.e. nrs. B 591, BD 617, 
and BD 622. 
Figs. 24, 25, and 26 show the course of the K values and !PV in these animals 
during the first year, and Fig. 27 gives the GTT and insulin secretion patterns 
found a year after the transplantation. At that time the fecal proteolytic 
enzymes were again determined; the values are shown in Table XV HI. 
5. DISCUSSION 
5.1. Weight loss 
In the 3 weeks after the pancreatectomy the mean weight loss amounted to 
23 per cent. After the transplantation there was no further loss of weight in the 
dogs with a longer survival time and the body weight returned to the level 
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Fig. 23. Insulin peak values of 5 dogs in group 3e after pancreas a/lotransplantatio.'L 
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Figs. 24, 25, and 26. Endocrine function of pancreas allotransplant over a period of a year in 
3 dogs. 
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Fig. 27. The intravenous GTT values and the insulin secretion pattern a year ajier pancreas allo-
tran;,p/antation in 3 dogs. 
TABLE XVII[ 
Fecal proteolytic enzyme levels one year after transplantation (in IU) 
Dog nr. :.:-chymotrypsin trypsin 
B 591 
BD617 
80622 
1.3 
0.0 
0.4 
0.0 
0.0 
0.0 
prevailing before the pancreatectomy. Since there was no loss of weight in the 
group of dogs in which only the pancreatic ducts were ligated, we are of the 
opinion that loss of weight is caused solely by the diabetes mellitus and not by 
the absence of the exocrine function of the pancreas. 
5.2. Endocrine function 
We found that immediately after transplantation a high level of insulin secretion 
occurred which could lead to hypoglycemia in the first two days after trans-
plantation. CERRA et a/. (21) showed that there is a relationship between the 
duration of the ischemic time and the level of the insulin secretion, and con-
cluded that the elevated serum insulin level is the direct result of cell damage 
caused by ischemia. On the other hand, GRENIER et a/. (51) observed high 
insulin levels just prior to rejection but without any change in the serum glucose 
level. On one occasion we by chance measured a very high IPV probably just 
before rejection; this could possibly be explained by the measurement of 
proinsulin rather than insulin. With the immunological method we applied, 
however, pro insulin cannot be distinguished from insulin. 
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In the dogs with a longer transplant survival before rejection there was a 
gradual decrease in the K values and the IPV a few weeks before rejection, as 
seen in groups 3c and 3e. For the dogs whose transplant functioned longer than 
a year, the K values were the same a year after transplantation as pre-opera-
tively but the IPV lay higher than the pre-operative values, although within 
normal limits. 
5.3. Histocompatibility 
The mean transplant survival time of group 3a (unrelated, non-identical 
beagles) was 9.6 days, that of group 3b (related, non-identical beagles differing 
by 2 haplotypes) 10.5 days, and that of group 3c (related, identical beagles with 
0 haplotype difference) 42.9 days. Fig. 28 shows these results graphically. The 
difference between groups 3a and 3b is not significant (P = 0.33), as can be 
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Fig. 28. ,il,fean sunival time of duct-ligated pancreas atlograjts in beagles. 
Group Ja: unrelated, non-identical beagles. MST = 9.66 (SD 2.39) 
Group Jh: related, non-identical beagles (2 hap/. di./f). MST = 10.55 (SD 7.22) 
Group 3c: related, identical beagles (0 hap!. di./f). MST= 42.90 (SD 22.9) 
Group 3d: related, identical beagles ( 1 hap!. d~ff) given azathioprine and prednisone. 
MST ~ 34.20 (SD 22.0) 
Group 3e: related, non-identical beagles ( 1 hap!. diff) given ALS. MST =--=- 57.30 
(SD 29.0) 
86 
50 -
40 -
30 -
20 
-
10 -
days 
TRANSPLANTATION OF DUCT-LIGATED PANCREAS 
I I 
group 3a 
n~9 
group 3b 
n ~ 9 
group 3c 
n ~ 10 
Fig. 29. Median survival time of duct~ligated pancreas allografts in the absence of immuno· 
suppression. (Wilcoxon's 2-samp!e test, one-sided.) 
Group Ja- Group Jb P = 0.33 (not significant) 
Group Jc- Group Ja P = 0.0005 (significant} 
Group Jc- Group Jb P = 0.0005 (significant) 
seen from Fig. 29. The significance of the differences in survival time between 
groups 3a, 3b, and 3c was calculated with Wilcoxon's two-sample test. The 
difference between groups 3c and 3a and between groups 3c and 3b is signi-
ficant (P ~ 0.0005). These results indicate the influence of compatibility for 
the histocompatibility system on the transplant survival time, and are analogous 
to the findings for heart (15), kidney (147), skin (142), and intestine (146) allo-
transplantations. There is no reason to assume that in this respect the pancreas 
allotransplant reacts differently from otherwise vascularized allotransplants. 
5.4. Immunosuppression 
For group 3d (related, non-identical beagles differing by 1 haplotype, treated 
with azathioprine and prednisone) the mean transplant survival time was 34.2 
days, for group 3e (related, non-identical beagles differing by 1 haplotype, 
treated for 6 weeks with ALS) 57.3 days. The median survival times are shown 
in Fig. 30. In the dosages applied, ALS was more effective than the combination 
of azathrioprine and prednisone. ALS also gave better results, even with the 
short period of administration in the non-identical group, than in the identical 
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rl·g. 30. iV!edian survival time of duct-ligated pancreas allografts under immunosuppression. 
(Wilcoxon's 2-sample test, one-sided.) 
Group 3e- Group 3d P = 0.021 ( sign(ficant) 
group without immunosuppression (see Fig. 28). The use of ALS had the 
disadvantage, however, of the toxic effect on the blood cells of the recipient. 
Furthermore, it is not known to what extent subsequent blood transfusions, 
which these animals received, have a positive or negative effect on the survival 
time of the transplant. Further discussion of this problem would, however, 
take us beyond the scope of this investigation. 
5.5. Microscopical appearance 
The findings made in the microscopical investigation fall into two main groups: 
I) changes caused by pancreatitis resulting from ligation of the pancreatic ducts, 
and 2) changes associated with rejection of the transplant. 
5.5.1. Histological changes due to pancreatitis and duct hgation 
One of the first signs of pancreatitis was the occurrence of interstitial edema, 
followed some time later by infiltration of polymorphonuclear cells and dila-
tation of the capillaries. This was in turn followed in some cases by necrosis 
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of the acinar cells in which it was often uncertain whether the cause was auto-
digestion or acute ischemia. This parenchymal necrosis was usually limited to 
a few areas but in a few cases more extensive necrosis had affected the capillaries 
as well, resulting in local hemorrhages. This process progressed until all of the 
acinar tissue was replaced by connective tissue. The islet tissue, however, re-
mained intact. In our material hemorrhagic pancreatitis was only observed once 
(BD 0.193). At autopsy, extensive loss of acinar cells with early proliferative 
fibrosis was observed in this dog a few days after transplantation. 
In general, pancreatitis with mild interstitial edema was observed up to the 
15th day, occurring later only once, on the 29th day (BD 0.283). Six cases 
showed not only interstitial edema but also focal necrosis of the parenchyma. 
A small amount of acinar tissue was found in one dog (BD 2.204) 27 days after 
duct ligation. All pancreases examined later than that showed complete fibrosis 
of the acinar tissue, with in one case cyst formation (B l.l83). 
5.5.2. Histological changes due to rejection 
In general, these changes were characterized by the infiltration of mononuclear 
cells (lymphocytes, lymphoblasts, and plasma cells) in the interstitium, initially 
at the periphery and later penetrating through the acinar tissue. After that, the 
islets were infiltrated by these cells. The first evidence of damage to the capil-
laries was swelling of the endothelium and blood stasis. In the small arteries 
intimal swelling was followed by fibrinoid necrosis of the media and, in a later 
stage, thrombus formation. 
In these untreated cases with short transplant survival (e.g. groups 3a, 3b) 
the interstitial cellular rejection picture predominated. One dog in group 3b 
(BD 0.283), however, survived 29 days, and here the vascular component 
dominated. In the dogs of group 3c (untreated dogs with longer transplant 
function), the interstitial component was in general slightly less pronounced 
and such vascular lesions as intimal swelling and fibrinoid necrosis were more 
evident. This was particularly marked in group 3d (non-identical, treated with 
azathioprine and prednisone), where little mononuclear cell infiltration was 
seen, but the vasculitis was so strong that it led to thrombosis and such extensive 
necrosis that the islets could no longer be recognized microscopically. 
A different picture was seen in group 3e (non-identical, treated with ALS). 
These transplants showed more mononuclear cell infiltration and the vascular 
component was weaker. Thrombosis and necrosis did not occur, but intimal 
swelling and fibrinoid necrosis of the media developed. As a result, the struc-
tures within the fibrotic areas could be distinguished and intact islets were seen 
frequently. 
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6. CONCLUSIONS 
[n the first 3 weeks after total pancreatectomy the mean weight loss amounted 
to 23 per cent. After transplantation of a pancreas with only the endocrine 
function persisting, the weight increased. Thus, the primary cause of the loss 
of weight must be diabetes mellitus and not enzyme dificiency. Furthermore, 
it also indicates that the transplant can regulate the diabetes better than 
parentally administered insulin does. 
Three weeks after the administration of insulin was started in pancreatectom-
ized dogs, antibodies to porcine insulin could already be demonstrated in 3 of 
the 47 dogs. In allotransplantations of a pancreas with ligated ducts large amounts 
of insulin reach the circulation immediately after revascularization, which can lead 
to hypoglycemia and hypokalcemia. Equilibrium between insulin production 
and the serum glucose level is only reached 48 hours after an allotransplanta-
tion, and only then can the parenteral administration of glucose be stopped. 
There is no significant difference with respect to the mean transplant survival 
under non-identical conditions between related and unrelated, DL-A non-
identical pairs of beagles. Related, DL-A identical beagle donor-recipient pairs 
had a significantly longer transplant survival. Low dosages of azathioprine and 
prednisone also have a favorable effect on the mean transplant survival time, 
but not to the same degree as ALS. Since a mild pancreatitis developed during 
the first 14 days after transplantation and only one case was seen after that, it 
is possible that in the cases of shorter survival pancreatitis may be a factor 
which, together with rejection, leads to the elemination of the endocrine func-
tion of the transplant. 
The rejection of the pancreas was characterized by mononuclear cell infil-
tration, first in the interstitium and then also in the acinar tissue and peri-
vascularly. The islet tissue is not infiltrated until a later stage is reached. The 
vascular anomalies predominate more strongly the longer the survival of the 
transplant. These phenomena were extremely pronounced in the dogs given 
azathioprine and prednisone. 
In the animals treated with ALS the histological results showed intimal 
swelling and fibrinoid necrosis without thrombosis and parenchymal necrosis, 
in contrast to the animals treated with azathioprine and prednisone. 
If rejection does not occur, the acinar tissue is replaced by connective tissue 
in which islets are clearly distinguishable. This fibrosis resulting from the liga-
tion of the pancreatic ducts has no influence on the endocrine function of the 
pancreas when an adequate diet is provided. 
A year after heterotopic allotransplantation of a canine pancreas with ligated 
ducts, the endocrine function is normal. 
CHAPTER VI 
General discussion 
The experiments reported in the preceding chapters were performed to deter-
mine whether duct ligation influences the function of the pancreas and whether 
the combination of duct ligation and allotransplantation of the pancreas has 
a harmful effect on the endocrine function of the organ. From the results 
described in three chapters certain relationships can be drawn which provide 
answers to the questions posed in the introduction. 
1. THE EFFECT OF LIGATION OF THE EXOCRINE DUCT ON THE ENDOCRINE FUNCTION 
OF THE PANCREAS 
After the ligation of the exocrine duct cfthc canine pancreas ;n situ we observed 
a distinct reduction of endocrine function of the organ. After some time, how-
ever, this function improved and reached about 75 per cent of the pre-operative 
values. At no time, however, was diabeted mellitus observed. 
There is no concensEs of opinion in the literature with respect to the effect 
of ligation of the exocrine ducts on the endocrine function of the pancreas. 
A number of investigators (2,35, 74) saw an unequivocal reduction of the 
endocrine function and even diabetes mellitus, but others found no diminish-
ment (4,22, 66, 121, 127). One objection which can be raised to the studies of 
the former group of authors is thct after elimination of the exocrine function 
no pancreatic enzymes were supplied or only inadequate amounts, which leads 
to reduced conversion of carbohydrates into glucose and this in turn can result 
in endocrine hypofunction. With respect to the studies of the latter group of 
investigators, objections can be raised to the parameters applied for the evalu-
ation of the endocrine function. In some cases only the possible presence of 
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diabetic blood sugar values was investigated (l2l), but usually non-diabetic 
GTT curves were compared without calculation of the K values. Our results 
indicate that the endocrine function indeed diminishes in connection with the 
pancreatitis, but a substantial part of this function is recovered when an 
adequate diet is provided. This fact is not mentioned by any of the authors 
referred to above. The mild pancreatitis that develops after ligation of the 
pancreatic ducts also does not have an unfavorable effect on the functioning of 
the beta cells. From the literature (8, 109) and our results (Chapter IV) it seems 
that in all probability the more severe the pancreatitis the greater the drop in 
endocrine function after duct ligation. Therefore, the way in which the pan-
creatitis resulting from the ligation is treated can constitute one of the important 
factors determining the ultimate endocrine function of the pancreas. 
In sum, it may thus be said that ligation of the pancreatic duct leads directly 
to pancreatitis which causes a reduction of the endocrine function of the organ, 
but a large part of this function can be restored by adequate diet and treat-
ment. 
2. THE ENDOCRINE FUNCTION OF THE PANCREAS AFTER HETEROTOPIC TRANSPLAN-
TATION OF THE ORGAN WITH LIGATED EXOCRINE DUCTS 
The authors who ligated the pancreatic ducts some time before the transplan-
tation, e.g. BEAVEN eta/. (8) in autotransplantations and SEDDON & HoWARD 
(127) in allotransplantations, obtained very good results. This can be attributed, 
in our opinion, to the distinction made between two kinds of factors which 
induce pancreatitis, on the one hand ischemia and surgical trauma and on the 
other duct ligation. 
In Chapter IV mention was made of the reasons why the surgical trauma to 
the organ is less severe in allotransplantation than in autotransplantation. In 
addition, with the technique we applied the blood supply to the allotransplant 
is better than that to an autotransplant and, furthermore, the venous drainage 
via the portal vein is such that it does not promote pancreatitis (136). In our 
opinion, these factors account for the higher percentage of success in 2111o-
transplantations as compared with autotransplantations. After allotransplan-
tations there is also hardly any loss of endocrine function. This can be com-
pletely explained by the less severe pancreatitis as compared with the form seen 
after autotransplantations. 
ff, however, we compare the endocrine function in the group of dogs in 
which only the pancreatic ducts were ligated with that of the allotransplantation 
group, the pancreatitis no longer offers a valid explanation of the differences. 
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[n view of the methods applied there is no reason to expect a more severe form 
of pancreatitis in one of these 2 groups. The reason for the better post-operative 
endocrine function after allotransplantation can be sought much more logically 
in the heterotopic localization of the organ, by which the insulin reaches the 
peripheral circulation directly, avoiding the liver which would take at least 
50 per cent of the supply (80). This would also explain the high insulin values 
found in the course of time, as described by BERGAN & TEIXEIRA (12). Their 
results are, however, neither confirmed nor contradicted by the findings in our 
material. 
In the phase immediately after the operation, thus, the loss of endocrine 
function due to the pancreatitis caused by the duct ligation would be com-
pensated for by an elevated insulin level in the p~ripheral blood, as has also 
been described by HEARN & PATON (61) and LEVEEN eta!. (91). The fact that 
we did not find high insulin peak values shortly after autotransplantation can 
be satisfactorily explained by the higher number of beta cells rendered defective 
by the pancreatitis. 
3. INFLUENCE OF TISSUE TYPING ON THE SURVIVAL TIME OF A HETEROTOPIC PAN-
CREAS ALLOTRANSPLANT 
By the use of tissue typing for SO determinants of the OL-A complex we hoped 
to obtain prolonged transplant survival while avoiding the influence of immuno-
suppressive drugs on the results of the function tests. Our experiments indeed 
showed a significant difference in transplant survival between related DL-A 
identical beagles on the one hand and related and unrelated OL-A non-
identical beagles on the other. This is in agreement with the results obtained in 
dogs with kidney transplantations (144), heterotopic gut-segment transplan-
tations (145), and orthotopic heart transplantations (15). 
The use of beagles typed for SO determinants of the OL-A complex made 
it possible to follow a number of animals for a very long time after pancreas 
allotransplantation. Three of the dogs could even be followed for more than 
a year and at the time of writing were still alive with good endocrine function. 
4. INFLUENCE OF IMMUNOSUPPRESSIVE DRUGS ON THE HETEROPTOPIC PANCREAS 
ALLOTRANSPLANT 
The results obtained in the group of dogs which were not given immunosup-
pressive drugs and had a long transplant survival and those obtained in the 
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group with a long transplant survival after treatment with such drugs, were 
analysed in an attempt to distinguish a possible relationship between histo-
compatibility and an influence of the immunosuppressive drugs on the endo-
crine function of the pancreas. No information is available about the influence 
of ALS and azathioprine on this endocrine function, but prednisone is known 
to have a distinct diabetogenic effect (88). 
Because we had shown that with respect to tissue typing the pancreas allo-
transplant does not differ from other organs, it could be assumed that the mean 
transplant survival time for a difference of one haplotype would lie between 
that of the identical dogs and those differing by two haplotypes (142). Treat-
ment of recipients differing by one haplotype from the donor with a low dose 
of immunosuppressive drugs was expected to give a mean survival time ap-
proaching that of the identical group, thus permitting comparison. In com-
parison with the untreated group, there proved to be no difference in the course 
of the endocrine function in the ALS-treated group or the group treated with 
a combination of azathioprine and prednisone, but there was divergence in the 
histological findings. It must be kept in mind here, however, that we used a 
lower dosage of prednisone than had been applied by other investigators (51, 
62, 76, 94, 152). This also means that little importance should be attached to 
the fact that longer transplant survival times were obtained with ALS than with 
azathioprine and prednisone in combination, since a higher dosage of the latter 
would probably have led to longer survival. The histological differences are, 
however, important. They showed that the vascular rejection phenomena were 
most prominent in the group treated with azathioprine and prednisone. 
5. IMPLICATIONS OF THE RESULTS 
It seems justified to conclude from the results of the present study that trans-
plantation of the entire pancreas with ligated pancreatic ducts is perfectly 
feasible, at least in the dog, and that the pancreas transplant behaves in the 
same way as other vascularized transplants. This means that it is unnecessary 
to perform the complicated operations described in the literature for the pre-
servation of enzyme secretion. In addition, the pancreatitis which develops 
proved to have little importance. It is not known whether this would also be 
the case for the human pancreas, but the acute pancreatitis seen in animals is 
reported to be anatomically, histologically, biochemically, and physiologically 
indistinguishable from that in man (9). 
On this basis we are of the opinion that for vascularized pancreas transplan-
tation in patients, preference should be given to a transplant consisting of the 
entire organ with ligated ducts. 
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Experiments reported by a number of investigators (6,23,90) in which islets 
or even beta cells in suspension were transplanted allogenically by applying 
them intraperitoneally or injecting them into the portal circulation, were only 
successful in isologous rat strains. This raises questions concerning, for instance, 
the regenerative capacity of beta cells in rats and whether degeneration of these 
cells would occur eventually because they reach an isolated location or because 
the total volume is too small (88, 97). Furthermore, in view of the technical 
difficulties involved in obtaining a sufficient number of beta cells from a single 
pancreas to provide adequate endocrine function after transplantation, it seems 
possible that transplantation of a vascularized pancreas will ultimately prove 
to be a more feasible method, the more so because preservation and perfusion 
of the pancreas for 24 hours is possible. This subject lies outside the present 
scope, but has been discussed by the author elsewhere (55, 56). 
Experimentally, it is now possible to perform pancreas allotransplantation 
in dogs with spontaneous juvenile diabetes. We are continuing this experimental 
work too, in the hope of finding answers to a number of questions concerning 
the pathophysiology of diabetes mellitus 
Summary 
The relevance of pancreas transplantation is discussed in the Introduction to 
this thesis. Chapter I gives the historical background, the specific problems in 
relation to previous research, the surgical techniques applied, and a review of 
the clinical pancreas transplantation performed so far. The conflicting results 
published by various investigators concern the long-term quality of the endo-
crine function of the organ when the exocrine function is abolished by ligation 
of the pancreatic ducts. As a result, in extensive series of experimental pancreas 
transplantations and a number performed in patients the endocrine function 
was maintained intact, which can only be achieved by including the duodenum, 
applying the Roux technique for anatomosis with the pancreas, or establishing 
an anastomosis between the pancreatic duct and the ureter. The disadvantages 
of these methods are discussed and the advantages of transplanting the pancreas 
with ligated ducts are indicated. The latter method requires only a vascular 
anastomosis and is in fact even less complicated than a kidney transplantation. 
On the basis of these considerations we thought it worthwhile to investigate 
the effects of transplantation of the pancreas with ligated ducts. This study was 
performed in dogs, and the effect of tissue typing for SO determinants of the 
DL-A complex on allograft survival was included in the investigation. 
The experimental design and the techniques applied are discussed in Chap-
ter II. Three groups of dogs were formed: one group to be given only duct 
ligation, one for autotransplantation with ligated ducts, and the third for 
hoteroptopic allotransplantation with ligated ducts. This last group was sub-
divided according to compatibility or non-compatibility for the major histo-
compotibility complex (DL-A) and the use or omission of immunosuppressive 
drugs. The method of anesthesia, the histological methods, and the laboratory 
determin:ltions (with special attention to the K values of the glucose tolerance 
test and the insulin peak values) are described, as well as a method for the 
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determination of the proteolytic enzymes in the feces as an indication of the 
exocrine function. The importance of these enzyme determinations is also 
discussed. 
The experiments performed to study the effect of pancreatic duct ligation on 
long-term endocrine function are discussed in Chapter III. Sixteen mongrel 
dogs underwent ligation of the pancreatic ducts and were followed for 2 years. 
It was found that the operation according to Markowitz did not completely 
eliminate the exocrine function in a number of cases. After duct ligation 
the endocrine function of the pancreas dropped sharply and then began to 
improve, reaching about 75 per cent of the original value within a year and 
remaining there throughout the second year. The results led us to conclude that 
in the dog ligation of the pancreatic ducts does not cause diabetes mellitus in 
the long run. 
Pancreas autotransplantations performed in 17 mongrel dogs are described 
in Chapter fV. The operation was successful in 5 cases, but only one dog could 
be followed for 5 years. At the end of the fifth year this dog was killed and 
functioning pancreatic tissue was found at the site of the autotransplant. The 
vascular relationships which contributed to the low percentage of successful 
canine pancreas autotransplantations are discussed. 
The allotransplantations are dealt with in Chapter V, starting with the 
measures taken to maintain the animals in good physical condition after total 
pancreatectomy. The criteria that the pancreatectomized dogs had to satisfy 
to serve as recipient are discussed. The differences in histocompatibility, the 
immunosuppressive drugs used, the surgical technique, and the post-operative 
treatment are also discussed. The results obtained in 77 dogs subjected to total 
pancreatectomy are reported and the cause of death during or shortly after the 
transplantation is indicated. The 5 subgroups are then discussed separately. 
Tissue typing proved to have a significant influence on transplant survival. At 
the end of this chapter special attention is given to the endocrine function of 
3 dogs with a survival time of more than a year; this function was found to be 
virtually the same as the level observed before the pancreatectomy. 
Lastly, the theoretical background and the implications of the results are 
discussed in relation to divergent findings made by other investigators. 
Samenvatting 
Nadat in de inleiding is uiteengezet waarom pancreastransplantatie wenselijk 
is, wordt in het eerste hoofdstuk, na een kort historisch overzicht, een opsom-
ming gegeven van de specifieke problemen bij pancreastransplantaties met een 
globaal overzicht van het onderzoek dat daarvoor al is verricht. De operatie 
technieken worden genoemd en er wordt een overzicht gegeven van de tot nu 
toe verrichte klinische pancreastransplantaties. Hieruit blijkt, dat er tegen-
strijdige uitkomsten bestaan bij verschillende onderzoekers als het gaat om de 
kwaliteit van de endocriene functie van het pancreas op de lange duur, wanneer 
de exocriene functie is uitgeschakeld door middel van onderbinding van de 
ductus pancreaticus. Dit heeft ertoe geleid, dat bij grote series experimentele 
pancreastransplantaties en cen aantal humane pancreastransplantaties deze 
exocriene functie intact is gehouden. Dit kan in de praktijk aileen door of het 
duodenum mee te transplanteren, of een technische procedure volgens Roux toe 
te passen, of door de ductus pancreaticus met de ureter te anastomoseren. Bij 
de probleemstelling in hoofdstuk I word! op de nadelen van bovenvermelde 
technieken gewezen en de voordelen van een te transplanteren pancreas met 
onderbonden ductus pancreaticus vermeld. Voor een dergelijk transplantaat 
dient aileen een vaatanastomose te worden gemaakt en dit zou in feite eenvou-
diger zijn dan een niertransplantatie. Op grond van deze overwegingen leek 
het ons de moeite waard een onderzoek in te stellen naar de mogelijkheid 
pancreastransplantaties met onderbonden afvoergang te verrichten. Dit onder-
zoek werd uitgevoerd met voor SD determinanten van het DL-A complex ge-
typeerde honden. 
In het tweede hoofdstuk worden de proefopstellingen en gebruikte technieken 
besproken. Drie groepen honden werden gevormd. Een groep waarbij aileen 
ductus onderbinding zou plaats vinden, een groep waarbij een auto-transplan-
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tatie met ductus onderbinding zou worden verricht en tenslotte een groep han-
den waarbij een heterotope pancreas allo-transplantatie met onderbonden 
ductus pancreaticus zou worden toegepast. De laatste groep werd uitgesplitst 
in subgroepen naar gelang de typering en eventueel gebruik van immuno-
suppressiva. In dit hoofdstuk werden nog apart besproken de narcose, de histo-
logische technieken en de laboratorium bepalingen, waarvan vooral van belang 
zijn de K-waarden van de GTT en de insuline piekwaarden. Verder wordt een 
methode beschreven om de proteolytische enzymen in de faeces te bepalen als 
controle op de exocriene functie en wat de betekenis hiervan is. 
In hoojdstuk III worden de experimenten besproken, die bij 16 bastaardhonden 
zijn verricht. De ductus pancreaticus werd b{j deze proefdieren onderbonden en 
vervolgens werd deze groep twee jaar lang bestudeerd. Het bleek, dat na los-
koppelen van bet pancreas volgens de methode van MARKOWITZ er toch in een 
aantal gevallen geen volledige uitval van de exocriene functie was. De endo-
criene pancreasfunctie daalde aanzienlijk na het onderbinden van de pancreas-
afvoergang, doch herstelde zich binnen het jaar tot ± 75 procent van de oor-
spronkelijke waarden. Deze functie handhaafde zich gedurende de tweejarige 
follow-up periode. Geconcludeerd werd, dat na onderbinding van de pancreas-
afvoergang bij de hond op den duur geen diabetes mellitus ontstond. 
In hoojdstuk IV worden pancreas auto-transplantaties beschreven, die verricht 
zijn bij 17 bastaardhonden. De auto-transplantatie was succesvol by 5 honden, 
doch slechts een hond kon gedurende 5 jaar vervolgd worden. Na 5 jaar werd 
deze hond opgeofferd, waarbij functionerend pancreasweefsel werd aangetoond 
op de plaats waar het auto-transplantaat was ingebracht. Er wordt verder in dit 
hoofdstuk nog ingegaan op de vasculaire verhoudingen, die mede verantwoor-
delijk zijn voor het lage succes-percentage van de pancreas auto-transplantatie 
bij de hond. 
In ho0fdstuk V worden de allo-transpiantaties besproken. Allereerst wordt be-
schreven hoe de proefdieren na totale pancreatectomie in goede conditie wor-
den gehouden en welke criteria werden gehanteerd voor een pancreasloos proef-
dier om als orgaan-ontvanger te kunnen fungeren. Beschreven wordt verder de 
histocompatibiliteits verschillen, de gebruikte immuno-suppressieve middelen, 
de post -operatieve therapie en de opera tie techniek. Eerst worden de resultaten 
genoemd bij 77 honden die een totale pancreatectomie ondergingen. Ingegaan 
wordt op de doodsoorzaak tijdens of direct na de transplantatie. De 5 getrans-
planteerde sub-groepen worden daarna afzonderlijk besproken. Het blijkt, dat 
weefseltypering een significante invloed heeft op de transplantaatoverleving. 
A an het einde van dit hoofdstuk word! nog ingegaan op de endocriene functie 
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van drie honden, die Ianger dan een jaar overleefden. Het blijkt, dat deze endo-
criene functie praktisch gelijk is aan de functie v66r de pancreatectomie. 
ln hoofdstuk VI tens lotte wordt aan de hand van resultaten van andere onder-
zoekers, voor zover die afwijken van de onze, op de theoretische achtergronden 
ingegaan en worden de consequenties van de resultaten besproken. 
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PLATES 113 
Plate 1. Pancreas 6 months after duct ligation (dog nr. 477). 
Plate 2. Normal canine pancreas. X 100. 
114 TRANSPLANTATION OF DUCT-LIGATED PANCREAS 
Plate 3. Islet tissue showing fibrosis of acinar tissue 6 mont Irs after duct ligation (dog nr. 477) 
X 250. 
Plate 4. Vascular anastomosis 5 years after autotransplantation of pancreas with ligated ducts 
(dog nr. 16). 
PLATES 115 
Plate 4a. Duodenum of dog nr. 16, 5 years after pancreatectomy for autotransplantation. 
Plate 5. Islet tissue of a pancreatic autotransplant after 5 years, showing complete replacement 
of the acinar tissue by fibrotic connective tissue (dog nr. 16) x 250. 
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Plate 6. Islet tissue 5 years ajier autotranspla/1/ation (dog nr. 16; aldehyde fuchsin staining). 
Note alpha and beta cells. 
Plate 7. Pancreas witlr ligated ducts during flus/ring witlr cold saline. 
PLATES 117 
Plate 8. The aortic patch with the celiac and superior mesenteric arteries, before anastomosis. 
Plate 9. The same pancreas as in Plate 8, after revascularization. 
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Plate 10. Representative histological picture of pancreas rejection after 5 days. X 40. 
Plate 11. Detail of Plate 10. x 250. 
PLATES 119 
Plate 12. Allotransplant on 69th day, showing cellular infiltration of isler tissue, loss of acinar 
tissue, and survival of ~uct tissue. No immunosuppressive drugs given. ( Nr. BD 9.161) X 250. 
Plate 13. Allotransplant on 59th day, showing islet tissue and damaged acinar tissue with ex-
tensive fibrosis and moderate cellular infiltration. No immunosuppressive drugs given. ( Nr. BD 
0.164) X 100. 
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Plate 14. Detail of Plate 13, showing islet tissue and ductal proliferations (nr. BD 0.164) X 250. 
Plate 15. Case exemplifying severe arteritis and thrombosis with rejection phenomena, 69 days 
after transplantation (nr. BD 9. 161) X 100. 
PLATES 121 
Plate 16. Representative histological picture of pancreatic allograft rejection under ALS treat-
ment, after 33 days. Slight cellular infiltration and only a little swelling of the intima (nr. BD 
619) X }00. 
Plate 17. Arteritis with proliferation of intimal cells (nr. BD 619) X 250. 
122 TRANSPLANTATION OF DUCT-LIGATED PANCREAS 
Plate 18. Vasculitis and fibrinoid necrosis after treatment with azathioprine and prednisone for 
30 days (nr. B 1.180) X 100. 
Plate 19. Detail of Plate 18. X 300. 
PLATES 123 
Plate 20. Pancreatic fibrosis in section showing intact islets (nr. B 1.180) x 300. 
Plate 21. Islet in area of fibroid degeneration (nr. B 1.180) X 300. 
124 TRANSPLANTATION OF DU CT- LIGATED PANCREAS 
Plate 22. Detail of Plate 20, showing afferent arteriole. X 500. 
- :· ... ~. l ~ ~ \1' \~ 
Plate 23. Contrast radiogram showing the arterial supply of the canine pancreas. 
